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Abstract 
ABSTRACT 
Ribosome inactivating proteins (RIPs) are a family of plant proteins that depurinate the 
major rRNA, thus arresting protein synthesis. RIPs are divided into type 1, single chain 
proteins with enzymatic activity, and type 2 RIPs (toxic and non-toxic), which contain the 
enzymatic chain linked by a disulfide bridge to the binding chain. RIPs have been used alone 
or as toxic component of immunotoxins for experimental therapy of many diseases. Still 
today many unanswered questions remain about the cell death mechanisms induced by RIP. 
The knowledge of cell death pathway(s) induced by RIPs could be useful for clarifying the 
mechanisms induced by RIPs and for designing specific immunotherapy. 
The purpose of the current study was to (i) determine the amino acid sequence of toxic 
type 2 RIP stenodactylin and compare with the sequence of other RIPs (ii) study the cell death 
mechanisms induced by stenodactylin in human neuroblastoma cells (NB100) and (iii) study 
the cell death pathway induced by the non-toxic type 2 RIPs ebulin l and nigrin b, and 
compare the results with the ones obtained with other RIPs. 
Stenodactylin is the most toxic type 2 RIP. Comparison between stenodactylin and other 
RIPs, reveals that the amino acid residues that are involved for the enzymatic activity of RIPs 
were conserved within the sequence of the A chain of stenodactylin. The B chain of 
stenodactylin showed a positive charge in the sugar binding site 2γ. Phylogenetic trees 
showed that the A chain of stenodactylin is related to ricin and other toxic RIPs, whereas the 
B chain is more related to the non-toxic type 2 RIPs. 
The pathogenesis of cell intoxication induced by stenodactylin was investigated using 
NB100 cells, which showed to be very sensitive to RIPs. High doses of stenodactylin (IC100) 
can activate the effector caspases (perhaps through the DNA damage and/or intrinsic/extrinsic 
pathways) and also causes ROS generation. 
To elucidate the temporal dynamic of events caused by stenodactylin, the cells were 
intoxicated with toxin at its IC50. The results showed that the RIP caused a caspase-dependent 
apoptosis, mainly via extrinsic pathway. Moreover, the activation of caspases precedes the 
inhibition of protein synthesis.  
Ebulin l and nigrin b show high enzymatic activity in a cell-free system, but they lack 
high cytotoxicity. Both toxins showed 106-105 times less toxic in NB100 cells than 
stenodactylin and ricin, and 103 times than saporin. Preliminary studies demonstrated that the 
cell death mechanism induced by the two non-toxic RIPs was partially caspase-dependent 
apoptosis, but other cell death mechanisms seem to be involved.  
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Ribosome Inactivating Proteins: generality and historical note 
Ribosome inactivating proteins (RIPs) are rRNA N-glycosidases present in some species of 
plants and bacteria that depurinate the major subunit of rRNA, thus arresting protein 
synthesis. Since ancient time, the biological effects of RIPs are known, for example the 
abortifacient activity of some medical plants such as Trichosanthes kirilowii and Mormordica 
charantia, and the poisonousness of the seeds of castor bean (Ricinus communis) and jequirity 
bean (Abrus precatorius). 
The scientific history of RIPs started in 1888 when Stillmark linked the toxicity of castor bean 
to the property of agglutinating erythrocytes. Soon after, different ricin-like toxic proteins 
have been identified, i.e., in the seeds of Abrus precatorius (abrin) and in the 1920s in the 
roots of Adenia digitata (modeccin). Following, Lin and co-workers demonstrated that RIPs 
were more toxic to tumor than to normal cells (Lin et al., 1970). Later, it has been discovered 
the two chain structure of the toxins with carbohydrate binding/lectin activity and inhibitory 
activity on protein synthesis. These enzymes have been called type-2 RIPs to distinguish them 
from RIPs that possess a single chain structure, which have been denominated type-1 RIPs. 
Structural and genetic studies have indicated that type 1 and type 2 RIPs evolved from a 
common ancestor gene (Ready et al., 1984). RIPs inhibit irreversibly the protein synthesis by 
preventing the ribosome from binding elongation factor 2 (EF-2) in eukaryotes and factor G 
(EF-G) in prokaryotes. The mechanism was resolved by Endo and co-workers (Endo et al., 
1987). The authors discovered that the enzymatic activity of RIPs is based on the N-
glycosidation cleavage of the specific adenine corresponding to the residue A4324 of 28S 
rRNA in the 60S subunit of rat ribosomes. This adenine is located in the α-sarcin-ricin loop 
and is conserved in large rRNAs from bacteria to humans (Mehta and Boston, 1998). 
During the last decades a lots of RIPs have been isolated, characterized and cloned, for their 
application in human therapy.  
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1.1 General properties 
1.1.1 Definition and Subdivision of RIPs 
The term RIPs was introduced by Stirpe to define plant proteins that inactivate animal 
ribosomes when the enzymatic activity and the structure were unknown (Stirpe et al., 1982). 
The designation RIP can be associated with their enzymatic activity, namely RNA N-
glycosylase activity. All proteins that catalyze the endohydrolysis of the N-glycosidic bond at 
one specific adenine of the large ribosomal RNA are considered rRNA N-glycosylases (EC 
3.2.2.22). Other proteins can inactivate or damage ribosomes by different mechanisms (e.g., 
RNases or proteases) but are not called RIPs; it is thus important to associate the term RIP 
with proteins that exhibit this N-glycosylase activity. Subsequently, it has been found that 
some RIPs remove more than one adenine residue per ribosome (Barbieri et al., 1994). Based 
on the observation that some RIPs remove adenine residues from DNA and other 
polynucleotides (Barbieri et al., 1997), the term adenine polynucleotide glycosylase was 
proposed for these proteins (Barbieri et al., 2001).  
Currently, the term RIP is reserved for proteins containing an RNA N-glycosidase domain 
that is structurally related to the classical RIPs. 
RIPs are classified into three groups based on their physical properties and the absence or 
presence of a lectin-like chain. A schematic representation of the most characteristic RIP 
structures is presented in Figure 1.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1 A schematic representation of type 1 and type 2 RIPs. 
Type 1 RIP 
Active chain 
Type 2 RIP  
A chain B chain 
Carbohydrate -
binding domains 
-S-S- 
Carbohydrate 
 side chains 
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1.1.1.1 Type 1 RIPs  
This group of RIPs contains i.e., pokeweed antiviral protein (PAP), saporin (from Saponaria 
officinalis L.), dianthin (Dianthus caryophyllus) and momordin (Momordica charantia). Type 
1 RIPs are monomeric enzymes of approximately 30 kDa. They are basic proteins (usually 
with a pI ≥ 9.5) that share a number of highly conserved active cleft residues and secondary 
structures within the active site despite showing differences in overall sequence homology 
and post-translational modifications (Nielsen and Boston, 2001). Different studies on protein 
and DNA sequence have shown that most type 1 RIPs are synthesized as pre-proproteins 
composed of a signal peptide, the mature protein and a C-terminal extension (Chow et al., 
1990). Detailed localization studies have demonstrated that these cytotoxic proteins are 
located in vacuoles or other extracytoplasmic compartments. For example, PAPs are observed 
in the cell wall matrix and in some vacuoles (Ready et al., 1986), and saporin is present in the 
intercellular spaces and in the paramural region between the primary wall and plasmalemma 
and within the vacuole (Carzaniga et al.,1994). Type 1 RIPs are divided into three sub-groups 
(Van Damme et al., 2001). The first sub-group is composed of “classical” type 1 RIPs, which 
are found in several dicotyledons; these enzymes are synthesized in the ER and then follow 
the secretory pathway to their final subcellular destination. The second sub-group of RIPs 
belongs to the Poaceae family (monocotyledons), and these enzymes are synthesized without 
a signal peptide. The third sub-group of RIPs is present in Z. mays and related (Panicoideae) 
species. These enzymes consist of two different polypeptides and are thus called “two chain” 
type 1 RIPs. These two chains are synthesized as inactive precursors. 
1.1.1.2 Type 2 RIPs 
Type 2 RIPs are divided into two groups: toxic (e.g., ricin, abrin, modeccin, viscumin, 
volkensin and stenodactylin) and non-toxic (e.g., ebulin and nigrin), based on differences in 
their cytotoxicity. 
These enzymes can be heterodimeric or tetrameric, with a molecular mass of 60 kDa or 120 
kDa, respectively. The polypeptide, with enzymatic activity (the A chain) is linked to a 
galactose-binding lectin (B chain) through a disulfide bond. The union of two heterodimers by 
another disulfide bond between the two B chains yields the tetrameric protein. The group of 
heterodimeric RIPs includes abrin, ebulin l, modeccin, ricin, volkensin, nigrin b and 
stenodactylin, while the tetrameric structure is typical of the Ricinus agglutinin (RCA). RCA 
consists of two identical heterodimers, is very similar to ricin, and is not linked by covalent 
bonds (Olsens et al., 1978). RCA was the first non-toxic type 2 RIPs to be identified. A 
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number of non-toxic type 2 RIPs have been found in some species of the genus Sambucus. 
The most representative and studied members are nigrin b, extracted from the bark of the 
common (black) elder Sambucus nigra (Girbes et al., 1993a), and ebulin l, purified from the 
leaves of the dwarf elder Sambucus ebulus l (Girbes et al., 1993b). Although the non-toxic 
type 2 RIPs show strong anti-ribosomal molecular activity in vitro, similar to ricin, they lack 
the high toxicity in cultured animals cells and in vivo rodents (103-105 less toxic than ricin) 
(Ferreras et al., 2011). The lectin chain can bind to galactosyl moieties of glycoproteins and 
/or glycolipidis that are present on the surface of eukaryotic cells and allow the translocation 
of the A chain into the cytosol. The non-toxic type 2 RIPs present individual changes in the 
high-affinity sugar binding sites of the B chains, which alter their intracellular trafficking can 
explain their different toxicity (Girbes et al., 2003). 
The type 2 RIPs derive from a pre-proprotein formed by a single precursor that consists of a 
signal peptide and two different domains separated by a linker peptide. The current 
understanding of the biosynthesis of RIPs is based on studies on ricin and RCA. The 
preproricin is co-translationally translocated into the endoplasmic reticulum (ER) lumen. 
During this process, the signal peptide is cleaved, four asparagines residues are N-
glycosylated, and five disulfide bridges are formed to obtain the proricin. The proricin is 
transported via the ER and the Golgi complex into protein storage vacuoles. During this 
transport, the glycosylate chains are converted into complex type N-glycan. In the protein 
bodies, the short peptide is cleaved from the N-terminus, and the excision of the linker yields 
the mature ricin, in which the A and B chains are linked by a disulfide bond (Lord et al., 
1994). Mature ricin is present only inside the protein bodies and is thus sequestered from the 
ribosome, preventing ricin from entering the cytoplasm and killing the cells. Nearly all type 2 
RIPs are synthesized and processed similarly. 
1.1.1.3 Type 3 RIP 
Type 3 RIP has an N-terminal domain that resembles type 1 RIPs, but the N-terminal domain 
is linked to an unrelated carboxyl-terminal domain with unknown function (Reinbothe et al., 
1994). This protein is expressed at lower levels than other RIPs and was identified in barley 
(where it is called JP60). Its gene does not contain a putative signal peptide, indicating that it 
is synthesized on free polysomes in the cytoplasm. Localization studies demonstrated that this 
protein is located in the nucleus and sometimes in the cytoplasm (Gorschen et al., 1997). This 
protein is synthesized in stress conditions and may correspond to an inducible suicide 
mechanism. 
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1.1.2 Distribution 
RIPs are widespread and almost ubiquitous in the plant kingdom, but not all the plants contain 
RIPs. For example, in the complete genome of Arabidopsis thaliana, no sequence that 
encodes a putative RIP has been found. RIPs have been detected in Angiospermae, both 
mono- and dicotyledons. Type 1 RIPs appeared to be more prevalent than type 2 RIPs, 
including some plants that are eaten raw and are in phylogenetically distant families such as: 
Asparagaceae, Caryophyllaceae, Cucurbitaceae, Euphorbiaceae, Nyctaginaceae, 
Phytolaccaceae and Poaceae (Table 1.1). Toxic type 2 RIPs have only been identified in six 
plants, which are members of Euphorbiaceae, Fabaceae, Passifloraceae, and Viscaceae, 
while non-toxic type 2 RIPs have been discovered in Euphorbiaceae, Sambucaceae, 
Lauraceae, Ranunculaceae, Liliaceae and Iridaceae (Table 1.2). The expression level of RIPs 
in plant tissues is highly variable, ranging from traces to hundreds of milligrams per 100 g, 
and they can be present in a single tissue or in all tissues of a plant (i.e., roots, leaves, fruits, 
seeds). Sometimes, several forms of RIPs were observed in the same tissue; for example, 
isoforms of saporin were discovered in the seeds, leaves and root of soapwort (Ferreras et al., 
1993), and several non-toxic RIPs have been identified in various tissues of Sambucus species 
(Girbes et al., 2003). In some plants, both toxic and non-toxic RIPs may exist (e.g., ricin and 
RCA in castor beans). 
The expression of RIPs in plants enhances during senescence, and unfavorable conditions, 
such as different stresses (Stirpe et al., 1996) and in virally infected cells (Barbieri et al., 
2001). 
RIPs are not limited to the plant kingdom. The type 1 RIPs stx 1 and stx 2 were isolated from 
Escherichia coli and Shiga toxin from Shigella dysenteteriae (Reisbig et al, 1981; Obrig, 
1997). Other RIPs have been detected in the alga Laminaria japonica (Liu et al., 2002) and in 
mushrooms (Lam and Ng, 2001).  
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Table 1.1: some type 1 RIPs 
TYPE 1 RIPS 
MAGNOLIIDAE 
Lauraceae Cinnamomun camphora seeds Camphorin 
CARYOPHYLLIDAE 
Aizoaceae Mesembryanthemum 
crystallinum leaves 
Mesembryanthemum 
crystallinum RIP1 
Amaranthus viridis leaves Amaranthin Amaranthaceae Celosia cristata leaves CCP 25 
Agrostemma githago seeds Agrostin 2,5 e 6 
Dianthus barbathus leaves Dianthin 29 
Dianthus caryophyllus leaves Dianthin 30 e 32 
Dianthus sinensis leaves RIP 1,2,3 
Lychnis chalcedonica seeds Lychnin 
Saponaria ocymoides seeds Ocymoidine 
seeds Saporin S5, S6, S8, S9 
leaves Saporin L1, L2 Saponaria officinalis 
 
roots Saporin R1, R2, R3 
Stellaria aquatica leaves Stellarin 
Caryophyllaceae 
Vaccaria pyramidata seeds Pyramidatine 
Beta vulgaris leaves Beetins 27 
Chenopodium album plants CAP30B Chenopodiaceae 
Spinacia oleracea roots SOP 
Bougainvillea spectabilis 
Willd leaves Bouganin 
Mirabilis expansa R&P roots ME1 and ME2 
roots MAP 
Nyctaginaceae 
Mirabilis jalapa 
seeds MAP-S 
leaves PAP I, PAP II 
seeds PAP-S1 e S2 
Phytolacca americana 
 
 roots PAP-R 
seeds PD-S1, S2, S3 Phytolacca dioica 
 leaves PD-L1, L2, L3, L4 
Phytolacca dodecera leaves Dodecandrin 
Phytolacca acinosa  PAP 
leaves PIP 
Phytolaccaceae 
Phytolacca insularis 
 cdna PIP 2 
ASTERIDAE 
Clerodendrum aculeatum leaves Protein CA-SRI 
Lamiaceae Clerodendrum inerme 
Gaerth leaves CIP-29 and CIP-34 
ROSIDAE 
Benincasa hispida var. 
chieh-qua seeds hyspidin 
leaves Bryodin-L 
 
 
 
 
Bryonia dioica 
roots Bryodin 1 e 2 
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Luffa acutangula seeds Luffaculin 
Luffa aegyptiaca seeds LRIP (Luffin c) 
Luffa cykubdruca seeds Luffin a e b 
Luffa cylindrica seeds Luffin S 
 seeds Luffacilina 
Marah oreganus seeds Mor I e II 
Momordica balsamina  Momordin II 
seeds Momordin I 
seeds α, β MMC Momordica charantia 
 
seeds Charantin 
seeds Momorcochin S Momordica 
cochinchinensis roots Momorcochin R 
Trichosanthes cucumerina 
var. anguina 
seeds Trichoanguin 
Trichosanthes 
cucumeroides roots Β trichosanthin 
Trichosanthes kirilowii 
Maximowicz 
Trichosanthes kirilowii 
seeds Trichokirin α,  
β kirilowina 
seeds S-Trichokirin 
 
 
Cucurbitaceae 
 
Trichosanthes kirilowii 
roots Trichosanthin TAP29 TCS α, β, γ  
Croton tiglium seeds Crotin I e II (2, 3) 
Gelonium multiflorum seeds Gelonin (GAP) 
Jatropha curcas seeds Curcin 2 
Manihot palmat seeds Mapalmin 
Euphorbiaceae 
Manihot utulissima seeds Manutin 1 e 2 
Pisum sativum var. arvense 
Poir seeds Pisavin α, β Fabaceae Pisum sativum var. 
macrocarpon legums Sativin 
ASTERIDAE 
Sambucus ebulus leaves Ebulitin α, β, γ Sambucaceae Sambucus nigra fruits Nigritin f1 e f2 
LILIIDAE 
Agavaceae Yucca recurvifolia leaves YLP 
Asparagaceae Asparagus officinalis seeds Asparin 1, 2 
Liliaceae Muscari armeniacum L. e Miller bulbs Musarmin 1, 2, 3 
Iridaceae Iris holleica var. Prof. Blaauw bulbs IRIP 1, 2, 3 
Hordeum vulgare seeds Barley RIP, JIP60 
Secale cereale seeds RPSI 
germ Tritin 
leaves Tritin L 
 
Triticum aestivum 
 seeds Tritin S 
Poaceae 
Zea mays seeds Mais RIP1, b-32 
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Table 1.2: some type 2 RIPs toxic and non-toxic. 
 
 
 
 
 
 
NON-TOXIC TYPE 2 RIPS 
MAGNOLIIDAE 
Cinnamomum, camphora seeds cinnamomin Lauraceae Cinnamomum porrectum seeds porrectin 
Ranunculaceae Eranthis hyemalis bulbs EHL, Eranthis hyemalis lectin 
ROSIDAE 
Euphorbiaceae Ricinus communis seeds RCA (Ricinus 
communis agglutinin) 
Fabaceae Abrus pulchellus seeds 
 
Pulchellins 
ASTERIDAE 
leaves Ebulin l 
rizhome Ebulin r1 e r2 Sambucus ebulus 
 fruits Ebulin f 
fruits Nigrin f, SNA-If 
barks 
Nigrin b, SNAI, SNAI’ 
Basic Nigrin b, 
SNLRP1 2 
leaves Nigrin l1 e l2, SNAld 
Sambucus nigra 
 
seeds Nigrin s, SNAIII 
Sambucus racemosa barks Basic racemosin 
Sambucaceae 
Sambucus sieboldiana 
 
barks Sieboldin b and SSA 
LILIIDAE 
Liliaceae Poligonatum multiflorum leaves PMRIPm e PMRIPt 
Iridaceae Iris holleica var. Prof Blaauw bulbs IRA-b e IRA-r 
TOXIC TYPE 2 RIPS  
ROSIDAE 
Euphorbiaceae Ricinus communis seeds Ricin (D, E) 
Fabaceae Abrus precatorius seeds Abrin a, b, c, d 
Phoradendron 
californicum leaves 
PCL, Phoradendron 
californicum lectin Viscaceae 
Viscum album leaves MLI (viscumin), II, III 
DILENIIDAE 
Adenia volkensii roots Volkensin 
Adenia lanceolata caudex Lanceolin 
Adenia stenodactyla caudex stenodactylin 
 
Passifloraceae 
Adenia digitata roots Modeccin 4B  and  6B 
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1.1.3 Molecular Evolution 
Several aspects of the evolution of RIPs are known, but many questions remain unanswered. 
A contribution for the compression of RIP evolution comes from genome studies.  
The RNA N-glycosidase domain derives from a common ancestor gene presents for over 300 
millions years. From this domain derived: the type 1 and the type 2 RIPs after a fusion of 
RNA N-glycosidase domain with a sugar binding domain. The latter seems to be acquired by 
later transfer from bacterium. This hypothesis is supported by (i) the B chain shows a high 
similarity with carbohydrate-binding part of a β-glycosidase-like glycosyl hydrolase and an α-
L-arabinofuranosidase B family protein from the Actinomycete bacterium C.acidiphila, and 
(ii) the cysteins important for the disulfide bond are present in the bacterial sequences 
(Peumans and Van Damme, 2010).  
Type 2 RIPs group is formed by three sub-groups: the classical type 2 RIPs, the truncated 
type 2 RIPs (called also secondary type 1 RIPs) and B lectin group. Although the truncated 
type 2 RIPs are formed only by A chain, they are not related with type 1 RIP. Indeed, they 
arose from type 2 RIP, that belong to Cucurbitaceae, Euphorbiaceae and Iridaceae families, 
which lost the lectin domain by three independent evolutionary events (Van Damme et al., 
2001). The type B lectin RIPs have been isolated from cucumber (C. sativus) roots (Masuda 
et al., 1999) and from several Sambucus species. The type B protein SNAII is formed by the 
A chain deletion of the genuine type 2 RIP (SNA-V) (Van Damme et al. 1997; Girbès et al., 
2004).  
1.2 Biological activities 
1.2.1 The enzymatic activity 
Early studies found that ricin inhibits protein synthesis both in cells and in a cell-free system, 
by preventing the ribosome from binding elongation factor 2 (Montanaro et al., 1973; 1975). 
The mechanism underlying the ribosomal damage was discovered by Endo and co-workers. 
Based on ricin studies, they found that ricin recognizes a specific and highly conserved region 
in the large subunit of rRNA and then cleaves the N-C glycosidic bond between a specific 
adenine and the nucleotide on the rRNA. Using the rat liver ribosome, the authors 
demonstrated that the specific adenine removed (A 4324) is inside a GAGA sequence that is 
present in an universally conserved loop (the sarcin/ricin domain) and is located at the top of a 
stem in 28S rRNA (Endo et al., 1987) (Fig. 1.2). This observation was extended to other 
RIPs, which are officially classified as rRNA N-glycosidases (EC 3.2.2.22) (Stirpe et al., 
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1988). However, there are marked differences in substrate specificity. For example, PAP 
deadenylates ribosomes from bacteria, plants and yeast, while ricin shows a strong activation 
on mammalian and yeast ribosomes, but not on plants or E. coli ribosomes. Type 1 and type 2 
RIPs have a different substrate specificity, and type 1 RIPs have a broader spectrum of 
activity than type 2. Because the GAGA loop presents 14 nucleotides that are highly 
conserved from E.coli to humans, the different sensitivity may be due to ribosomal proteins 
that allow or prevent access of the RIPs to the sarcin/ricin loop (Vater et al., 1995). The 
different RIP structures may also cause the diverse ribosome substrate specificity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2. Enzymatic mechanism of ribosome inactivating proteins. 
Through the development of fluorescence-based HPLC-methods (Zamboni et al., 1989), RIPs 
were shown to act on other substrates. For example, most RIPs show an effect on herring 
sperm DNA and poly(A), and one-third of the RIPs also act on RNA from tobacco masaic 
virus (TMV) (Barbieri et al., 1997). Based on the observation that RIPs can deadenylate a 
range of polynucleotides, the term polynucleotide: adenosine glycosidases and then adenine 
polynucleotide glycosylase was proposed (Barbieri et al., 2001). Some RIPs also exhibit a 
guanosine glycosidase activity, and can remove guanine residues from both eukaryotic and 
prokaryotic rRNA (Endo et al., 1987 and Rajamohan et al., 1999). This a guanosine 
glycosidase activity activity has only been observed in two RIPs, i.e., PAP and ricin, and is 
undetectable in gelonin, momordin, PAP-s and saporin-S6, which only remove adenine 
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(Barbieri et al., 2000). Hudak and co-workers found that PAP depurinates capped mRNA. 
This activity may contribute to the antiviral activity of RIPs (Hudak et al., 2002).  
1.2.2 Interaction of RIPs with cell: uptake and routing 
The cell-RIP interaction shows that protein synthesis is inhibited at least 30 min after the RIP 
is introduced. Only a few molecules reach their target (Sandvig et al., 1976), but one 
molecule is sufficient to induce cell death (Eiklid et al., 1980).  
Type 1 RIPs show lower toxicity compared with type 2 RIPs. This difference is related to the 
different interactions of these proteins with cells, which appear to depend on the protein 
structure. In particular, the presence of lectin-containing B chains allows the RIP to bind to 
the cell membrane and enter the cell. The low cytoxicity of type 1 RIPs is explained by the 
absence of lectin chain, which reduces entry to the cells (Barbieri et al., 1993). 
Studies on type 2 RIPs have identified different mechanisms through which the RIPs bind to 
the cell surface. The B chain has galactose-specific lectin activity, which allows the protein to 
interact with the galactose-containing glycoproteins and glycolipids that are present on the 
surface of every cell type. An alternative mechanism involves the interaction of mannose cell 
receptors with the carbohydrate side chains that are present in the toxin.  
Studies on ricin demonstrated that after interaction with the receptor, the toxin enters into the 
cytosol through the endocytic pathway. Ricin and possibly other RIPs can reach the 
endosomal compartment through two distinct mechanisms: the clathrin-dependent or clathrin 
-independent pathways (Sandvig and van Deurs, 1996).  
Once inside the cells, RIPs follow an intracellular pathway through which the RIP molecules 
have three different destinations: (i) some RIPs translocate to the Golgi apparatus, then to the 
ER and finally to the cytoplasm; (ii) a certain fraction of RIPs are degraded after lysosomal 
internalization; and (iii) some RIPs are expelled from the cells (Sandvig and van Deurs, 2005) 
(Fig. 1.3). The altered destination and processes could cause different cytotoxicity. Indeed, 
the non-toxic type 2 RIP nigrin b enters cells, equally as ricin, but nigrin b is more rapidly and 
extensively degraded and excreted from cells (Battelli et al., 1997). The number of lysines is 
also important. Although volkensin is excreted by cells faster than ricin, it shows higher 
toxicity. One possible reason is that volkensin, similar to ricin and abrin, has few lysines, 
which make it resistant to proteolysis. As a consequence, the non-degraded form is excreted 
by cells and is available for further entry into the cells (Battelli et al., 2004; Chambery et al., 
2004). Stenodactylin and lanceolin, the most toxic type 2 RIPs that have been discovered, 
have the same intracellular routing observed for ricin. After binding to a receptor, they are 
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internalized by clathrin-independent endocytosis and reach the Golgi apparatus. Their high 
cytotoxicity seems to be related to their high affinity to receptors, greater uptake and lower 
proteolysis, which allows the re-uptake of non-degraded RIPs (Battelli et al., 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3. Endocytosis of  the ricin A chain. Endocytosis by the clathrin-dependent pathway (1) and clathrin-
independent pathway (2), inclusion within the endosome (3), lysosomal internalization for degradation (4), 
transportation of the A chain to the Golgi apparatus (5), and finally expulsion outside the cells (6) or into the 
cytoplasms (7).  
The endocytic mechanism of type 1 RIPs is still not well understood. Two mechanisms have 
been proposed: (i) endocytosis after binding to either the galactosyl residues or the mannose 
receptor on the cell membrane and (ii) the passive “fluid phase” endocytosis (pinocytosis), 
which allows the internalization of the toxin without receptor binding (Madan and Ghosh, 
1992). Saporin-S-6 enters into cells through the binding of the α2-macroglobulin receptor 
(Cavallaro and Soria, 1995). In some cells, however, there was no correlation between the 
level of this receptor and the sensitivity to saporin S-6, indicating a α2-macroglobulin 
receptor-independent mechanism (Bagga et al., 2003a). Studies on the intracellular routes that 
are followed by type 1 RIPs show diversity within this group. Saporin, which enters into cells 
by via receptor-mediated endocytosis, has a Golgi-independent pathway (a different 
intracellular movement compared with ricin) (Vago et al., 2005) and recently it has been 
observed a nuclear localisation of saporin (Bolognesi et al., 2012). In contrast, PAP presents a 
retro-translocation from the ER into the cytosol, similar to the mechanism utilized by type 2 
RIPs (Parikh et al., 2005). This observation suggests that type 1 RIPs may also be able to 
follow the cellular route for misfolded proteins without being degraded by the proteosome.  
Endoplasmic 
reticulum 
Nucleus 
Golgi 
Endosome 
Lysosome 
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1.2.3 Effects on laboratory animals and humans 
1.2.3.1 Toxicity and lesions 
The effect of type 2 RIPs on humans have long been after many people were poisoned with 
ricin. Low doses of ricin cause digestive tract convulsions, while higher doses produce 
gastrointestinal symptoms, with subsequent haemorrhaging in the stomach and intestine; 
degenerative changes in the heart, liver and kidney; and then death. When small particles are 
inhaled, severe respiratory symptoms followed by acute respiratory failure and death are 
observed (Balint, 1974). Little information is known about the effect of type 1 RIPs in 
humans. Type 1 RIPs have been reported to produce fever and rashes when trichosanthin was 
used to induce abortion (Lu and Jin, 1989) or administered to AIDS patients (Byers et al., 
1990).  
All RIPs are strongly immunogenic, and their administration to animals induces the formation 
of antibodies, with cross-reaction among RIPs of the same family (Strocchi et al., 1992). 
However, recently it has been observed that the type 2 RIP lanceolin cross reacts with sera 
against type 1 RIPs, momordin I and PAP R (Stirpe et al., 2007). Many type 1 RIPs, as well 
as ricin, are allergenic and induce the formation of IgE (Zheng et al., 1991). Allergenicity has 
also been observed in laboratory personnel working with RIPs, as in our laboratory. These 
toxins are present even in eaten raw, and their allergenic properties could be the cause of 
allergies induced by some vegetables (Stipe and Battelli, 2006).  
RIPs also display immunosuppressive activity both on the humoral- and cell-mediated 
response by interfering with an early step in the immune response (Spreafico et al., 1983).  
These toxins also have abortifacient activity. In China, trichosanthin is used to induce early 
and mid-term abortion, with over 95% success and minimal effects. It causes the death of the 
fetus by inducing necrosis of the syncytiotrophoblast cells and fragmentation of placenta villi 
when administered intra-amniotically ( Stirpe and Battelli, 2006). 
The effects of RIPs have predominantly been studied in rats, and severe damage has been 
observed in the liver, kidney and spleen. 
An electron microscopy study showed that in ricin-poisoned rats, Kupffer and sinusoidal cells 
appear to be damaged first, with subsequent necrosis of the hepatocytes. Moreover, necrosis 
of the macrophage-rich red pulp of the spleen was also observed (Derenzini et al., 1976). In 
addition, treatment with modeccin causes lesions in the liver and in hepatocytes (Sperti et al., 
1979). In contrast, abrin does not cause lesion formation in the liver or hepatocytes but 
instead induces necrosis of the acinar pancreatic cells (Barbieri et al., 1979). Subsequently, 
increase of apoptotic changes in lymphoid tissues in rats treated with abrin and ricin were 
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detected (Griffiths et al., 1987). In addition, high doses of type 1 RIPs in mice damages the 
liver, kidney and spleen, and necrosis and fatty changes were also observed in these mice 
(Battelli et al., 1990). In mice, high doses of nigrin b (a non-toxic type 2 RIP) cause gut 
derangement, especially of the small intestine (Girbés et al., 2003). Because all RIPs have the 
same enzymatic activity, the differences observed may be due to the different entry 
mechanisms into cells. The damage induced by RIPs, such as massive necrotic lesions and 
apoptosis, are different from the damage caused by other protein synthesis inhibitors. This 
difference suggests that RIPs have other effects beyond the inhibition of protein synthesis. 
Ricin (Licastro et al., 1993), viscumin (Hajto et al., 1990) and modeccin (Yamasaki et al., 
2004) induce the production of tumor necrosis factor (TNF) and interleukins by human 
mononuclear cells, which could explain the fever and general inflammation that are observed 
in animals poisoned with these toxins.  
1.2.3.2 Axonal transport and the effect on the nervous system  
Ricin, abrin, modeccin and viscumin are retrogradely transported along the axon to the 
neurons when injected into peripheral nerves. When injected in the central nervous system, 
only modeccin and volkensin are retrogradely transported to the peripheral nervous system. 
This specific transportation could be caused by their B chain, which allows their retrograde 
transport to other areas through the projecting neurons. Because these RIPs can be 
retrogradely transported, they were used to study the central nervous system by producing 
selective lesions (Wiley and Lappi, 1994). The retrograde transport of ricin along nerves 
which are relevant to the injected area, was observed when RIPs were injected outside nerves 
in several tissues, such as the anterior eye chamber (Dumas et al., 1979), the submandibular 
gland (Harper et al., 1980), the dental pulp (Henry et al., 1987), the superior lip (Hino et al., 
1988) and the lateral rectus muscle (de la Cruz et al., 1991). Recently, two potent type 2 RIPs, 
i.e., lanceolin and stenodactylin, were found to be retrogradely transported through axons to 
central nervous system, and even low doses of these toxins are highly neurotoxic, especially 
for microglia. These results all suggest that these toxins can be used to selectively lesion 
neuronal populations (Monti et al., 2007).  
1.2.4 Antiviral activity 
All type 1 RIPs and few type 2 RIPs show to posses antiviral activity against plants, fungal 
and animal viruses.  
Pokeweed antiviral protein (PAP) was the first to be discovered with this antiviral activity and 
is one of the most potent. It was found that the extracts from the leaves of pokeweed inhibited 
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the plant viral infection, such as tobacco mosaic virus (Grasso and Shepherd, 1978) cucumber 
mosaic virus (Tomlinson et al., 1974), and many others. When small amount of extract, which 
contained PAP and virus were mixed and rubbed on the surface of plants were able to block 
viral infection (Duggar and Armstrong, 1925). The mechanism of this activity is still not 
completely understood. Viral infection changes the permeability of cell membrane and allows 
RIPs (normally located in protein bodies, such as ricin, or in cell wall matrix or vacuole, as 
PAP, or in intracellular space, as saporin) to come into contact with plant ribosome of 
infected cells. The ribosome would be inactivated with subsequent cell death and block of 
viral replication (Fernández-Puentes and Carrasco, 1980). However, through recombinant 
techniques, it was found that ribosome inactivation is not necessary for the antiviral activity. 
Mutants of PAP, which lack their enzymatic activity, are not toxic when expressed in 
transgenic tobacco plants, but there are able to protect the tobacco plants against potato virus 
X (Tumer et al., 1997) and also fungal phatogen (Zoubenko et al., 1997). This suggested the 
idea that RIPs are able to damage directly the virus by their effect on DNA.  
RIPs showed to inhibit also animal viruses, for example blocking the viral replication of 
influenza virus (Tomlinson et al., 1974), polio virus, herpes simplex virus (Foà-Tomasi et al., 
1982) and HIV virus (Zarling et al., 1990). Studies on effects on HIV-1 infection by type 1 
RIPs confirmed the idea that their enzymatic activity and antiviral property are two distinct 
functions. For example, trichosanthin inhibits HIV RNA and protein accumulation without 
effecting host-cell gene expression (McGrath et al., 1990).  
1.3 Possible use in experimental and clinical medicine 
The role of RIPs in nature is still not clear. Their wide distribution and conservation 
throughout evolution suggest that one possible role of these proteins is to confer an advantage 
to plants, perhaps against pathogens and predators. Though many questions about their 
specific function in plants remain unanswered, RIPs have been used in medicine for several 
purposes, such as creating immunotoxins, anti-tumor therapy and immune disorders. 
1.3.1 Immunotoxins 
RIPs present a high cytotoxic effect, but they lack the selectivity needed for therapeutic use. 
To increase their specificity against undesired or harmful cells, RIPs have been combined 
with carriers that recognize select antigens or receptors that are expressed on the membrane 
surface of the targeted cells. Carriers that can be used include hormones, growth factors, 
receptors, lectins, antigens, and vitamin-binding proteins, but the most powerful and 
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frequently utilized carriers are monoclonal and polyclonal antibodies. When a RIP is 
chemically linked to an antibody or antibody fragment, it is called an immunotoxin (IT), in 
contrast, if the RIP and antibody are synthesized using DNA recombinant techniques, the 
resulting product is defined a recombinant immunotoxin. In the latter, the gene for the Fab or 
Fv fragment of an antibody is fused with the gene encoding a truncated toxin; the plasmid 
vector expressing the recombinant IT is then transfected into bacteria or yeast to produce the 
single-chain fusion protein.  
Both type 1 and of type 2 RIPs have been used for immunotoxins. Ricin is the most 
commonly used type 2 RIP, but the whole toxin is not required for this purpose because the B 
chain would allow non-specific binding to any cell. To avoid this non-specific binding, 
different strategies have been utilized: (i) the B chain can be blocked or modified; (ii) the 
deglycosylated A chain of ricin; and (iii) a non-toxic type 2 RIPs (e.g., ebulin l and nigrin b) 
have been utilized as the toxic part of immunotoxins (Stirpe, 2004). The type 1 RIPs that are 
most commonly used for immunotoxins are PAP, saporin and gelonin; when compared with 
the A chain of ricin, they are less dangerous, more stable and easy to prepare. Moreover, 
saporin-6 is more efficient than the A chain of ricin (Siena et al., 1988).  
Most immunotoxins have been prepared for use against cancer cells, the endothelial cells of 
tumor vasculatures, immunocompetent cells or cells infected by viruses. 
1.3.2 Anti-tumor therapy 
Several studies has been conducted with tumor transplanted in animals, and the results 
showed that the efficacy of the therapy appeared to be related to tumor size. ITs were more 
effective in preventing the development of neoplastic masses when the treatment was started 
soon after the inoculum of tumors (Pasqualucci et al., 1995). 
ITs have been used to cancer patients in phase I or I/II clinical trials against both solid and 
haematological tumors. Better results were obtained against hematologic malignancies, 
especially for lymphoma treatments (Frankel et al., 2003). Ricin A chain or blocked ricin 
were used in patients with B and T-cell leukemia and lymphomas (Bolognesi and Polito, 
2004) and ITs containing saporin and an anti-CD30 or CD22 monolconal antibody were given 
to patients with Hodgkin’s and non Hodgkin’s lymphoma respectively (Polito et al., 2011). 
ITs have been used also against solid tumor but the results were modest, probably because 
hematological neoplastic cells are easier to access and target in vivo compared to solid tumor 
cells. However, the use of immunotoxins in cancer therapy has not completely fulfilled the 
hope. Indeed, immunotoxins present some problems: formation of antibodies against carrier 
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and the RIP, capillary leak syndrome, hepatotoxicity and recurrence of the disease. The latter 
is probably caused by the advance state of the tumor in which the trial were performed. The 
immune response against the antibody could be overcome using humanized antibodies, 
whereas therapy with a rotation of different toxin could avoid the immune response against 
the RIP.  
1.3.3 Immune disorders 
ITs have been used also for autoimmune diseases. One approach was to conjugate saporin S-6 
with anti-idiotype antibodies, while another was to construct ITs with the antigens responsible 
for the disease. This antigen-toxin could combine with and kill the immunocompetent cells. 
IT composed of antiidiotypic antibody and saporin was utilized in the treatment of guinea pig 
B lymphocytic leukemia and as result the immunoglobulin-secreting leukemic cells were 
selectively eliminated (Glennie et al., 1987). Antigen-toxin IT has two main advantages: the 
carrier molecule is a human molecule, and their determinants are very small. Good results 
were obtained with ricin-tetanus toxoid conjugates which were able to selectively eliminate 
the specific antibody-producing B cell clones, without affecting the remainder of the B cell 
repertoire (Volkeman et al., 1982). The A chain of ricin was conjugate to human 
thyroglobulin for the cure of patients with Hashimoto disease (Rennie et al., 1983). Specific 
suppression of immune response to acetylcholine receptor was obtained in vitro with IT 
containing antibody against the nicotinic acetylcholine receptor and RIP, for the treatment of 
focal muscle spam (Hott et al., 1998), of strabismus by destroying oculomotor muscle 
(Christiansen et al., 2002) and for the therapy of myasthenia gravis (Hossann et al., 2006). 
RIPs have been also utilized for the prevention and treatment of graft versus host disease 
(GVHD). The first clinical applications of IT, made with toxic subunit of ricin, were the 
purging of the bone marrow of T cells to avoid GVHD both in allogeneic and autologous 
transplantation (Filipovich et al., 1984; Colombatti et al., 1984). Even saporin-S6, which is 
one of the most stable and active type-1 ribosome-inactivating proteins, has been used for this 
purpose (Tazzari et al., 2001; Polito et al., 2009b).  
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2.1 Materials  
RIPs 
Stenodactylin was purified from the caudex of Adenia stenodactyla as described by Stripe et 
al., 2007. Saporin was purified from the seeds of Saponaria officinalis as described by 
Barbieri et al., 1987. Ricin was purified from the seeds of Ricinus communis as described by 
Nicolson et al., 1974. Ebulin l was purified from the leaves of Sambucus ebulus as described 
by Girbés et al., 1993b. Nigrin b was purified from the bark of Sambucus nigra as described 
by Girbés et al., 1993a. 
Adenia plants were purchased from Exotica Botanical Rarities, Erkelenz-golkrath, Germany 
and, if not used immediately on arrival, were kept in the greenhouse of the Botanical Garden 
of the University of Bologna. 
Cell coltures 
The cell lines used were NB100 derived from human neuroblastoma, and COLO 320 derived 
from human colon carcinoma. RPMI 1640, fetal calf serum, L-glutamine, antibiotics, were 
purchased from Sigma-Aldrich (St.Louis, MO, USA). Trypan blue, and trypsin/EDTA were 
obtained from BioWhittaker (Vervies, Belgium).  
Cytotoxicity was evaluated using L-[4,5-3H] leucine purchased by GE Healthcare 
(Buckingam shire, UK). Flasks and plates were from Falcon (Franklin Lakes, NJ, USA).  
Antibodies 
Mouse anti-PARP, anti-R.I.P1, anti-BAD, anti-BAX antibodies were obtained from BD 
transduction Laboratories (Heidelberg, Germany). The horseradish peroxidise-conjugated 
anti-mouse or anti-rabbit IgG, rabbit anti-LC3, anti-rabbit TRITC were purchased from Sigma 
Aldrich. Rabbit anti-stenodactylin polyclonal antibodies were obtained as described by 
Strocchi et al., 1992.  
Kits 
The apoptosis was evaluated using the luminescent kit Caspase-Glo™3/7 Assay, Caspase-
Glo™ 2 Assay, Caspase-Glo™ 8 Assay, Caspase-Glo 9™ Assay (Promega Corporation, 
Wisconsin, USA) and the Annexin V-EGFP/PI detection kit (Biovision, Mt. View, CA).  
The viability was measured using the colorimetric CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay (Promega). The CellTiter 96® Aqueous One Solution Reagent contains a 
novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
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(4-sulfophenyl)-2H-tetrazolium, MTS] and an electron coupling reagent (phenazine 
ethosulfate; PES). 
The mitochondrial potential changes were detected using the Mitochondria Staining Kit 
(Sigma Aldrich). 
The oxidative stress was assayed by Total ROS/Superoxide Detection Kit (Enzo Life Science, 
Farmingdale, NY, USA).  
For RT-PCR analysis the GenElute Mammalian Total RNA Kit and the primers were 
purchased from Sigma-Aldrich. 
For stenodactylin sequence the total RNA was isolated using the RNeasy Minikit, whereas the 
plasmids were purified by QIAfilter plasmid purification kit, both purchased from QIAGEN 
(Valencia CA, USA). The PCR products were purified using the High Pure PCR Product 
Purification kit obtained from Roche Applied Science (Mannheim, Germany). The reverse 
transcriptase MuLV, the dNTPs were obtained from GeneAmp RNA PCR kit (Applied 
Biosystem, Roche, New Jersey, USA). The chemically competent E.coli INVαF´ and the 
pCR®II cloning vector were purchased from Invitrogen (Life technology-Carlsbad-CA, USA). 
Reactives 
The liquid scintillation was Ready-Gel (Beckman Instrument, Fullerton, USA). The reagents 
and the molecular weight standard were purchased from GE Healthcare.  
DAPI-Antifade was from Resnova SRL, Genzano di Roma, Italy. 
The pan-caspase inhibitor Z-Vad-fmk (carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-
fluoromethylketone) was supplied by Vinci-Biochem (Florence, Italy). The inhibitor of 
necroptosis necrostatin-1, catalase, superoxide dismutase and sodium pyruvate were obtained 
from Sigma-Aldrich. 
The Immobilon Western detection Reagent and the PVDF membrane were purchased from 
Millipore (Milford, MA, USA). 
For native-PAGE it was used the gel precasted and the buffer strips obtained from GE-
Healthcare. 
The iScript cDNA synthesis Kit and the SsoFast™ EvaGreen® Supermix were obtained from 
Bio-Rad (Hercules, CA, USA). 
Other reagents used were from Merck (Darmstadt, Germany), Carlo Erba, Milano, Italy and 
Sigma. 
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Instruments 
Cells were maintained at 37°C  in humidified atmosphere at 5% CO2 in the HeraCell Haereus 
incubator (Hanau, Germany). 
Cell-incorporated radioactivity was measured by a β-counter (Beckman Coulter, Fullerton, 
CA, USA).  
Morphological cell analysis was carried out with a digital camera from Motic Microscopes, 
(Xiamen,China). Fluorescence microscopy was performed with a Nikon Eclipse E600 
fluorescence microscope (Nikon instruments, Cadenzano, Firenze). 
Absorbance at 492nm was measured by a microtiter plate reader Multiskan EX, 
ThermoLabsystem, (Helsinki, Finland). 
Flow cytometry analysis, was done using the FACSAria BD analyzer (Franklin Lakes, New 
Jersey, USA). 
The luminescence was read using the Fluoroskan Ascent FL (Labsystem, Finland). 
Protein concentration was determined by UVICON 860 Spectrophotometer (Kontron 
Instruments, Milano, Italy). The DNA content was determined by Beckman DU 640 
spectrophotometer The protein were separated on SDS-PAGE and then blotting using the 
Mini Protean 3 Cell electro-blotting apparatus (Bio-Rad). 
The native PAGE analysis was conducted using the the PhastSystem (GE-Healthcare). 
RT-PCR was performed using the CFX96 Real-Time PCR System (Bio-Rad).  
PCR was conducted using the thermal cycler PCR system 2400 (Perkin Elmer). 
Statistical analysis 
Statistical analyses were conducted using the XLSTAT-Pro software, version 6.1.9 
(Addinsoft 2003). Result are given as means ±SD of three different experiments. Data were 
analyzed by ANOVA, followed by a comparison with Dunnett’s test.  
DNA sequencing Softwares 
A search for sequence similarity was performed with the BLAST program available on-line 
(http://www.ncv.nlm.nih.gov/BLAST). Multiple sequence alignment program ClustalW 
(http://npsa-pbil.ibcp.fr) was used to detect the extent of sequence conservation and the 
secondary structure prediction was carried out using PSIPRED (http://bioinf.cs.ucl.ac.uk). 
The tertiary  structure was predict using SWISS-MODEL (http://swissmodel.expasy.org). 
Phylogenetic tree was made in MEGA 5 using neighbor-joining analysis (Saitou and Nei, 
1987). 
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2.2 Methods 
2.2.1 Sequencing of stenodactylin 
2.2.1.1 Synthesis of cDNA 
The caudex of A.Stenodactyla was disrupted using mortar and pastle and grinded to a fine 
powder under liquid nitrogen. Approximately 100 mg of total RNA was isolated using the 
RNeasy Minikit (Qiagen) according to the manufacturer’s instruction. Poly(A)-rich RNA was 
reverse transcribed using the synthetic oligonucleotide J1 (5' 
CGTCTAGAGTCGACTAGTGC(T)20 3'). Approximately 2 µg of total RNA and 1µl of 
RNAse inhibitor were incubated at 65°C in a thermal cycler for 5 min. It was later cooled on 
ice for 1 minutes and it was added 15 µl of reaction mixture containing: 1×PCR Buffer PEII, 
5 mM of MgCl2, 1 mM of each dNTP, 10 µM of J1, and 100 U/µl of MuLV reverse 
transcriptase (Roche). The reaction mixture was incubated 20 min at 23°C, then for 20 min at 
42°C, and finally 5 min at 99°C. 
2.2.1.2. Reverse transcription 
The cDNA specific primers for full-length of stenodactylin were designed and synthesized 
based on the volkensin sequences. Three couple of primers were used to detect the full length 
amino acid sequence of stenodactylin (STA2-STB1R for A-chain; STA2-STB3R for A-chain 
and a piece of B-chain; STB1-STB5R for B-chain). The primer sequences are reported in 
Table 2.1. 
Table 2.1. Primer sequence 
 
 
 
 
 
 
 
For cDNA amplification 2 µl of the above-synthesize cDNA were used and 16 µl of master 
mix and 0.5 µM of each primers were added. A typical reaction master mix included: 1×PCR 
buffer/Mg2+, 0.25 mM dNTPs Mix, 2.5 U Taq Polymerase (Biotools, Madrid, Spain). PCR 
amplification was done with PCR conditions reported in Table 2.2. 
 
 
STA2 5' GCCACGGTAGAGAGRTACACT 3' 
STB1R 5' AAGTCGTCTCCCCGGAAGGGC 3' 
STB3R 5' GGCGGGGTTGATGGTTCC3' 
STB1 5' TGCCCTTCCGGGGAGACGACT3' 
STB5R 5' TAGGAACCATTGCTGGTTGGA3' 
 24 
Table 2.2. PCR condition 
Stage Step 
Temperature 
°C 
Duration 
N°. of 
cycles 
I 
 
 
II 
 
 
 
III 
Initial 
denaturation 
 
 
Denaturation 
Annealing 
Extension 
 
Final 
extension 
Hold 
94 
 
 
94 
55/54 
72 
 
72 
4 
5 min 
 
 
30 sec 
30 sec-45 sec 
2 min 
 
10 min 
1 
 
 
 
 
 
 
1 
 
About 5 µl of amplified products from each tube along with 3 µl of loading dye were 
separated on 0.8% agaroses gel using 1X TAE buffer along with HindIII / EcoRI double 
digest as DNA molecular weight marker. 
2.2.1.3 cDNA cloning 
The PCR product was purified using the High Pure PCR product Purification Kit (Roche) 
according to the manufacturer’s instruction.  
The purified PCR product was ligated into the pCR®II cloning vector (Invitrogen). For 
ligation, optimal molar ratio is 1:3 of vector: insert. The components of ligation mixture was 
mixed into a 0.5 ml microcentrifuge tube and incubated at 14°C overnight in a thermal cycler. 
The vector contains genes for ampicillin and kanamycin resistance that make it possible to 
select for transformed bacteria. 
The ligation mixtures were used to transform the Chemically Competent E. Coli INVαF´ 
(Invitrogen). E. coli INVαF′ cells were provided as frozen 50 µl aliquots with the TA Cloning 
® kit. The required number of tubes was thawed on ice. 5 µl of the ligation mixture was gently 
pipetted into the thawed competent cells and mixed gently. The tubes were incubated on ice 
for 30 min and then heat shocked for 30 sec in 42 °C water bath and then placed on ice for 2 
min. SOC medium provided with the kit was prewarmed to room temperature. 250 µl of 
prewarmed SOC medium was added onto each sample after the heat shock. The samples were 
incubated at 37 °C shaking horizontally at 225 rpm for 1 hr. 50 and 100 µl of each sample 
was spreaded onto a prewarmed LB/amp plate with 40 µl of XGal from the 20 mg/ml stock. 
After 15 min, the plates were inverted and incubated at 37°C overnight, and the following day 
35 
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the plates with colonies were stored at 4°C. The transformants colonies were analyzed. The 
white colonies (transformants clones) were screened by PCR using the appropriate couple of 
primers. Using a yellow tip the colony was dipped into a PCR tube and then streaked it onto a 
fresh agar plate using a numbered template. The PCR mix included: 0.25 mM dNTPs, 1× 
PCR Buffer, 1µM of each primers, 0.125 U Taq Polymerase (Biotools), PCR program was 
done as reported in Table 2.2. 
2.2.1.4 Isolation of the plasmids 
The positive white colonies from the agar plates were transferred to a Falcon tube each, 
containing 10ml LB-medium with 100 µg/ml ampicillin, and incubated overnight at 37°C at 
225 rpm. The cells were collected by centrifugation (2800 rpm for 10 min) and then purified 
using plasmid purification kit (Qiagen) following the manufacturer’s instructions.  
The DNA content or copy number of the plasmids was determined by measuring their 
absorbance at 260 nm where an absorbance of 1 is equivalent to 50 µg DNA/ml.  
Plasmid quality and the presence of sequence fragment was checked by running the 
precipitated samples on a 1% agarose gel by digestion with EcoRI. This gives information on 
conformation and structural integrity of isolated plasmid DNA. 
2.2.1.5 DNA sequence 
DNA sequencing was carried out on the CENIT Support system (Villamayor-
Salamnca,Spain). The sequence reactions were performed using pCRII plasmid and the M13 
and M13R universal primers, according to the manufacturer’s recommendations.  
2.2.2 Cell colture 
NB100 and COLO320 cells were maintained in the logarithmic phase of growth in RPMI 
1640 medium containing 10% heat-inactivated foetal bovin serum, 2 mM L-glutamine, 
100U/ml penicillin and 100 µg/ml streptomycin (hereafter named complete medium), in 
humidified air with 5% CO2 at 37°C. Cells were checked for the absence of Mycoplasma 
infection. 
2.2.3 Cell protein inhibition 
2.2.3.1 Cells 
NB100 cells (2×104/well) were seeded in 24-well microtiter plates in 250 µl of complete 
medium in the absence (control cultures) or in the presence of stenodactylin, ricin, saporin at 
concentrations ranging from 10-7 to 10-14 M in complete medium. After 48 h, cells were 
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incubated at 37°C for further 4 h with L-[4,5-3H] leucine (0.125µCi/well) (GE Healthcare) in 
serum and leucine-free medium. Protein synthesis was arrested with 20% trichloroacetic acid 
(TCA) for 30 min at 4°C. After three washes with 5% TCA, 200 µl/well of KOH 1N were 
added and incubation for 10 min at 37°C was performed. Cell-incorporated radioactivity was 
measured by a β-counter with Ready-Gel scintillation liquid containing 0.7% acetic acid. 
The IC50 and IC100 (concentration of RIP required to inhibit cell protein synthesis by 50% and 
100%, respectively), were calculated by regression analysis. 
2.2.3.2 Cell-free system 
Cell-free protein synthesis for ebulin l and nigrin b was determined with a coupled 
transcription-translation in vitro assay using the rabbit reticulocyte lysate system. The reaction 
mixture was composed of 4 µl rabbit reticulocyte lysate, 1.2 U/µl RNase inhibitor (Amersham 
Biosciences Inc., GE), 2.8 U/µl T7 RNA polymerase (Takara-Bio, Shiga, Japan), 0.24 mg 
luciferase T7 plasmid (Promega), and nuclease-free water to a final volume of 8 µl. The 
reaction tubes were incubated at 30ºC for 10min and chilled on ice. Then 1,6 µl of either 
water or dilutions of the respective RIP with increasing concentrations was added to the test 
tubes and the samples were incubated at 30ºC for 30 min. At this time 20 µl of water at room 
temperature were added to the sample and 28 µl of room temperature luciferase assay reagent 
in a luminometer tube. The relative luciferase activities of the samples were determined in a 
Luminova 1254 luminometer (BIO ORBIT) for 10 sec with an initial delay of 2 sec. The 
inhibitory effects of proteins were represented as the IC50 value which is defined as the 
amount of inhibitory protein that gives a 50% of inhibition of protein synthesis. 
2.2.4 Cell viability assay 
Cell viability was evaluated with the colorimetric assay CellTiter 96® Aqueous One Solution 
Cell Proliferation. This colorimetric kit allows to determine the number of viable cells. 
The MTS tetrazolium compound is bioreduced by cells into a colored formazan product that 
is soluble in RPMI medium. This conversion is presumably accomplished by NADPH or 
NADH produced by dehydrogenase enzymes in metabolically active cells. The quantity of 
formazan product is measured by the absorbance at 490nm. 
Cells (3×103/well) were seeded in 96-well microtiter plates in 100 µl RPMI complete 
medium. After 24 h, cells were incubated in the absence (control culture) or in the presence of 
stenodactylin, ricin, saporin, ebulin l, nigrin b at scalar concentrations (from 10-6 to 10-14 M) 
in complete medium. After the indicated times the medium was removed and 100 µl/well plus 
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20 µl/well of colorimetric kit solution were added. After 1 h of incubation at 37°C the 
absorbance at 492 nm was measured.  
2.2.4.1 Viability in the presence of inhibitors and/or scavengers 
The RIP cytotoxicity was also evaluated on NB100 cells pretreated with 100 µM of the pan-
caspase inhibitor Z-Vad-fmk, 100 µM of the necroptosis inhibitor necrostatin-1, 10 U/ml 
catalase, 10 U/ml heat inactivated catalase (65 °C for 30 min), 100 U/ml superoxide 
dismutase or 1 mM Sodium pyruvate. The reagents were added to NB100 cells 3 h before 
RIPs and they were re-added to cultures every 24 h. In cells treated with 10-12 M 
stenodactylin, the incubation with the RIP was only for 2 h. The 2h treatment was performed 
to evaluate the early effects of stenodactylin.   
2.2.5 Cell and nuclear morphology 
NB100 cells (2×104 /500 µl complete RPMI medium) were incubate with stenodactylin 10-12 
M in 24-well microtiter plates for 24, 48, 72, 96 h at 37°C. Morphology was assessed by 
phase contrast microscopy.  
For nuclear analysis, the NB100 cells (2×104 /500 µl complete RPMI medium) were seeded 
directly on a coverslips in 35 mm dishes for 48 h. After treatment with stenodactylin (10-12 M) 
for 24 h, the cells were washed with PBS and fixed with 2% p-formaldehyde (freshly 
prepared) for 30 min. After washing with PBS, the cells were incubated with 7 µl 
DAPI/antifade (4´,6-diamidino-2-phenylindole) and visualized under Nikon Eclipse E600W 
fluorescence microscope. 
2.2.6 Assessment of apoptosis 
Apoptotic cell death was examined by flow cytometry and by fluorescence microscope using 
Annexin V-EGFP/PI detection kit and by luminometer measuring caspase activation. 
The scavengers or the inhibitors were added 3 h before the RIPs were added and cells treated 
with 10-12 M stenodactylin, the incubation with the RIPs was for 2 h.  
2.2.6.1 Quantification by flow cytometry 
Cells (2 ×105/3 ml complete RPMI) were seeded in 25 cm2 flasks, and after 24 h, the cells 
were treated with stenodactylin (10-12 M), ebulin l (10-7 M) and nigrin b (10-7 M). After the 
indicating times the cells were centrifuged at 400×g for 5 min, washed in 2 ml fresh medium, 
centrifuged again and resuspended in 294 µl binding buffer provided in the kit. Annexin V-
EGFP (3 µl) and propidium iodide (3 µl) were added. Tubes were incubated for 10 min in the 
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dark at room temperature. Cells were analyzed by flow cytometry within 30 min, using the 
FACSAria BD analyzer. 
2.2.6.2 Detection by fluorescence microscopy 
Cells (1.5×104/500 µl) were seeded directly on a coverslips in 35 mm dishes 48 h prior the 
experiments. After the indicating time from the treatments, 198 µl binding buffer, 1 µl of 
Annexin V-EGFP and 1 µl of PI were added. Following incubation at room temperature for 
10 min in the dark, the coverslips were inverted on glass slide and the cells were observed 
under a Nikon Eclipse E600W fluorescence microscope equipped with a 60X objective 
(Nikon, Melville, NY). Image merge was obtained by Image J 1.42q software. 
2.2.7 Caspase -3/7, -8,-9,-2 activities 
The caspase -3/7,-8, -9, -2 were assessed by the luminescent assay Caspase-GloTM, specific 
for each caspase. Each kit provides a luminogenic caspase substrate, which contains the 
tetrapeptide sequence specific for each caspase (DEVD, VDVAD, LEHD, LETD for caspase 
3/7, -2, -9,-8, respectively). The caspase cleavages its substrate generating a luminescent 
signal, produced by luciferase. Luminescence is proportional to the amount of caspase activity 
present.  
Cells (4×103/well) were seeded in 96-well microtiter plates in 100 µl RPMI complete 
medium. After 24 h, the RPMI was removed and the cells were treated with 100 µl RPMI 
containing RIP (stenodactylin 10-12 M and 10-14 M; ricin 10-13 M; saporin 10-11 M; ebulin l 10-
7 M and nigrin b 10-7 M). After incubation at the indicating times, the medium was removed 
and 50 µl/well of RPMI and 50 µl/well of Caspase-Glo™ 2, Caspase-Glo™8, Caspase-Glo™ 
3/7 I were added. For caspase 9, 80 µl/well of RPMI and 20 µl/well of Caspase-Glo™ 9 were 
added. Plates were shaken at 420 prm for 1 min and then incubated for 20 min at room 
temperature in the dark. The luminescence was measured by Fluoroskan Ascent FL 
(integration time 10 sec) and the values were normalized for the viability. 
Caspase 8 inhibitor Z-IETD-fmk (z-Ile-Glu(OMe)-Thr-Asp(OMe) fluoromethyl ketone, 
Sigma-Aldrich) was added to the cell 3 h before RIPs, at the concentration of 25 µM.  
For the experiments with inhibitors or scavengers and stenodactylin (10-12 M), the RIP was 
added 3 h after the inhibitors and left in contact with cells for 2 h. The scavengers and the 
inhibitors were added every 24 h.  
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2.2.8 Measurement of mitochondrial membrane potential loss 
The change in mitochondrial membrane potential (∆ѱm) was measured using the cationic, 
lipophilic dye, JC-1 (5,5',6,6'-tetrachloro-1,1´,3,3´-tetraethylbenzimidazolocarbocyanine 
iodide) purchased from Mitochondria Staining Kit (Sigma). In health cells, due to the 
electrochemical potential gradient, the dye concentrates in the mitochondrial matrix, where it 
forms red fluorescent aggregates (J-aggregates). Any event that dissipates the mitochondrial 
membrane potential prevents the accumulation of the JC-1 dye in the mitochondria and thus, 
the dye is dispersed throughout the entire cell leading to a shift from red (J-aggregates) to 
green fluorescence (JC-1 monomers). 
Cells (2×104/500 µl) were seeded directly on a coverslips in 35 mm dishes 48 h prior the 
experiments. After the RPMI was removed and stenodactylin was added for 24 h (10-12 M) or 
for 16 h (10-14 M). At the end of the treatments, the cells were stained with 500 µl of JC-1 dye 
(1:100 in RPMI) and incubated at room temperature for 10 min in dark. The cells were then 
washed three times with Staining buffer purchased from the kit. The coverslips were inverted 
on glass slide and the cells were observed under a Nikon Eclipse E600W fluorescence 
microscope equipped with a 60X objective.  
2.2.9 Assessment of oxidative stress  
The oxidative stress was detected by using the Total ROS/superoxide Detection Kit, which 
through the combination of two specific fluorescent probes, it is enable to measure the global 
level of reactive oxygen species (ROS) and specifically superoxide in living cells. The total 
ROS detection dye (green) reacts directly with a wide range of reactive species, (e.g., 
hydrogen peroxide, peroxynitrite), while the superoxide detection dye (Red) is a cell-
permeable probe that reacts specifically with superoxide.  
2.2.9.1 Quantification by flow cytometry 
Cells (4×105/3ml complete RPMI) were seeded in 25 cm2 flasks, and after 24 h, the cells were 
treated with stenodactylin (10-12 M) for 8 h. Then the media was removed and the cells were 
washed twice with 1× Wash buffer purchased form the Kit. After trypsinization, the cells 
were centrifuged at 400×g for 5 min, and washed with the Wash buffer and collected in flow 
cytometry tubes. The cells were centrifuged at 400×g for 5 min and the cell pellet was 
resuspended in 500 µl of Superoxide Detection Mix, according to the manufacturer’s 
instruction. Cells were analyzed by flow cytometry within 30 min, using the FACSAria BD 
analyzer. 
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2.2.9.2 Detection by fluorescence microscopy 
Cells (1.5×104/500µl) were seeded directly on a coverslips in 35 mm dishes 48 h h prior the 
experiment. After, the medium was removed and 1 ml of RPMI containing stenodactylin (10-
12 M) was added for 8 h. Subsequently the medium was removed and was added 600 µl of 
ROS/Superoxide Detection Mix, according to the manufacturer’s instruction. Following 
incubation at 37°C for 1 h in the dark, the coverslips were inverted on glass slide and the cells 
were observed under a Nikon Eclipse E600W fluorescence microscope equipped with a 60X 
objective (Nikon, Melville, NY). Image merge were obtained by Image J 1.42q software. 
2.2.10 Native PAGE 
Stenodactylin and catalase were analyzed by polyacyilamide electrophoresis gels in native 
condition. The two proteins were incubated in Native Sample Buffer (40 mM Tris-HCl pH 
6.8, 0.005% bromophenol blue) for 20 min at 37°C. Then the samples were analyzed on the 
PahstGel 8-25 gradient using the PhastSystem instrument. The gel was stained with 
Coomassie Brilliant Blue G250 0.1% (w/v) in 50% methanol and 10% acetic acid.  
2.2.11 Immunofluorescence using anti-stenodactylin antibodies 
Cells (2.5×104/1ml) were seeded directly on a coverslips in 35 mm dishes 72 h prior the 
experiments. Then, the cells were cold-treated with stenodactylin (10-12 M), catalase (10 
U/ml) or in the combination of both. After 30 min at 4°C the cell were fixed with 1% p-
formaldehyde (freshly prepared). After 30 min at 37°C, the cells were washed three times 
with PBS and the 1% of BSA in PBS was added. After 1 h at 37°C, the cells were washed 
three times with PBS and was added anti-stenodactylin antibodies (1:1000 in 1% BSA). After 
2 h at 37°C and three washes, the anti-rabbit TRITC antibody (1:500) was added. After 1 h at 
37°C and three washes the coverslips were inverted on glass slide and the cells were observed 
under the fluorescence microscope.  
2.2.12 Western Blot analysis  
Cells (1×106/20 ml RPMI complete) were seeded in 75 cm2 flasks and, after 24 h, medium 
was removed and the stenodactylin (10-14 M or 10-12 M) was added. At different times of 
incubation, ranging from 8 to 24 h, cells were harvested with a cell scraper, collected by 
centrifugation at 500×g for 5 min a room temperature. Cell pellets were lysed by adding 100 
µl of Cell Lytic-M (Sigma-Aldrich) supplemented with Protease inhibitor Cocktail (1:100), 
Phosphatase inhibitor cocktail 1 (1:100) and sodium-orthovanadate (1:500). After 45 min at 
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0°C, vortexing every 5 min, insoluble material (nuclear pellet plus membranes) was removed 
by centrifugation at 12,000×g for 25 min at 4°C. Protein supernatant (cell lysate) was 
collected and stored a -20°C. Protein content was quantified by spectrophotometer using the 
Kalb and Bernlohr formula (Kalb and Bernlohr, 1977). The protein (50 µg/lane) were 
separated by SDS-PAGE (10% gel) and blotted for 45 min at 100 V to Immobilon 
(polyvinylidene difluoride, PVDF) membrane (Millipore). Non-specific antibody binding 
sites were blocked by incubation with blocking buffer (TRIS buffered saline, 0.1% Tween 20 
(TBS/T)) with 5% casein, for 1 h at room temperature. After 5 washes with TBS/T, 
membranes were incubated overnight at 4°C with various primary antibodies: anti-PARP 
antibody at 1: 2000 directed against uncleaved (116 kDa) and the cleaved form of PARP (85 
kDa), anti-BAD 1:5000, anti-BAX 1:1000, anti-LC3 1:5000 direct against LC3I (18 kDa) and 
LC3II (16 kDa), anti R.I.P1 1:2000, monoclonal anti-β-actin which detects β-actin (42 kDa) 
was used as protein loading control. All antibodies were diluted in TBS/T with 5% bovine 
serum albumin. After 5 washes with TBS/T, membranes were incubated for 1 h at room 
temperature with horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibody or 
goat anti-rabbit secondary antibody used at 1:10000, diluted in blocking buffer with 5% 
casein. After further 5 washes, proteins were detected by incubating the membrane with 
Immobilon Western detection Reagent (Millipore) according to manufacturer’s protocol and 
the image was taken on Kodak® BioMax light Film. The level of expression of different 
proteins was analysed by using the public domain software Image J.   
2.2.13 Real-time PCR Analysis 
Cells (2 ×105/well) were seeded in 6-well culture plates in complete medium. After 24 h the 
cells were treated with stenodactylin (10-14 M) for the indicating times. Total RNA from 
NB100 cells was isolated using the GenElute Mammalian Total RNA Kit (Sigma). RNA 
quantity was determined spectrophotometrically according to optical densities at 260 and 280 
nm, whereas its integry checked by a standard electrophoresis in agarose gel. cDNA was 
synthesized from 800 ng of the total RNA and the cDNA synthesis was performed using the 
iScript cDNA Synthesis kit (Bio-Rad) following the manufacturer’s direction, applying 4 µl 
of 5×iScript Mix, 1 µl of iScript reverse, the sample and Nuclease free water to the total 
volume of 20 µl. The reaction mix was incubate for 5 min 25°C, followed by 30 min 
incubation at 42°C, then 15 min 48°C, followed by 5 min at 85°C and then store the cDNA 
product at -20˚C. The resulting cDNA was used in the real time PCR reaction.  
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Real-time PCR was performed in 20 µl of reaction mixture consisting of 10 µl of 2×EvaGreen 
Supermix (Bio-Rad), 1 µl of each primer (final concentration of 0.4 µM) (Table 2.3), 3 µl of 
template and 6 µl of Nuclease free water. 
RT-PCR was performed using the CFX96 Bio-Rad Real-Time System and the following 
cycling program: enzyme activation for 30 sec at 98ºC, 44 cycles of denaturation for 3 sec at 
98ºC and annealing/extension for 8 sec at 60°C, and melt curve for 5 sec/step at 65°C-95°C 
(in 0.5°C increments). Triplicates of each sample were loaded in a 96 well plate.  
The threshold cycle (Ct) value for each gene was normalized to the Ct value of GAPDH. 
Relative mRNA expression was calculated by the following formula: 2-∆∆Ct where ∆Ct = 
Cttarget gene- Ctreference gene and ∆∆Ct = ∆Cttreated - ∆Ctcontrol. 
 
Table 2.3.  Primer sequences for RT-PCR 
 
Gene Primer sequence 
BAD F-GAGTGACGAGTTTGTGGAG 
R-CACCAGGACTGGAAGACT  
BAX F-AGCTGACATGTTTTCTGACG 
R-GCCTTGAGCACCAGTTTG 
GADPH F-CCCTTCATTGACCTCAACTACATG 
R-TGGGATTTCCATTGATGACAAGC 
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BACKGROUND: Primary and tertiary structure of RIPs 
The amino acid sequence and three-dimensional structure of many type 1 (e.g., saporin and 
dianthin) and type 2 (e.g., ricin, abrin and ebulin) RIPs are known and have been reported in 
the literature and the GenBank database. 
A comparison of these sequences shows the similarity between the type 1 and the A chains of 
type 2 RIPs and among the B chains of type 2 RIPs. However, the complete primary structure 
sequence homologies vary from 17 to 80%. Although highly variable, several amino acid 
residues seem to be important for the catalytic activity, and they are conserved in type 1 and 
in the A chain of type 2 RIPs. Based on the ricin A chain sequence, the conserved residues are 
Tyr80, Tyr123, Glu177, Arg180 and Trp211. The adenine-binding site can also hold guanine (in 
PAP and trichosanthin) or pteroic acid (in ricin and PAP) (Yan et al. ,1997; Kurinov et al., 
1999; Gu and Xia, 2000). This result suggests that N-glycosylase activity is not directed only 
to adenine but may also be directed toward other purine derivatives; however, this hypothesis 
is controversial. Near the active site, six other amino acids are important and conserved in 
both mono and bi-chain RIPs (with the exception of the type 1 RIPs from irises). These 
residues (Asn78, Arg134, Gln173, Ala178, Glu208 in ricin) are not involved in the depurination 
mechanism, but they help maintain the catalytic conformation (Katzin et al., 1991; Hao et al., 
2001). Site-direct mutagenesis studies have shown that mutating of amino acid important for 
the catalytic activity causes a substantial reduction in activity. Frankel and co-workers, found 
that a positive charge at position 180 is essential for solubility and enzyme activity; indeed, 
the conversion of Arg180 to His reduces the enzymatic activity almost 1000-fold (Frankel et 
al., 1990). Conversion of Glu177 to Gln reduces enzyme activity of 200-fold (Ready et al., 
1991). In type 2 RIPs, the A and B chains are linked by a disulfide bridge between two 
cysteines. In ricin, the two cysteines that are involved are Cys259 of the A chain and Cys4 of 
the B chain (Katzin et al., 1991). 
X-ray diffraction analysis indicates that the three-dimensional structures are well conserved 
between RIPs, with the only differences in the C-terminal region and the surface loop 
structure. Ricin was the first RIP analyzed by X-ray diffraction, and its structure was 
published 1987 (Montfort et al., 1987). The X-ray diffraction data demonstrated that the A 
chain is a globular protein that is folded into three domains that largely exhibits α-helical and 
β- strand structures. The A chain includes two N-glycosylation sites (Asn10-Phe11-Thr12 and 
Asn236-Gly237-Ser238), but these sites do not appear to be important for proper folding (Mlsna 
et al., 1993). The B chain folds into two topologically similar domains, and they are stabilized 
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by four disulfide bridges. Each fold is formed by 12 antiparallel β-strands that are connected 
by β-turns and Ω loops. Each fold is composed of three subdomains (1α, 1β and 1γ for 
domain 1 and 2α, 2β and 2γ for domain 2). Only two of these subdomains, 1α and 2γ, 
demonstrate galactoside-binding activity through a network of hydrogen bonds. Despite 
creating one more hydrogen bond, subdomain 1 presents with lower affinity for lactose than 
domain 2 (Hatakeyama et al., 1986). Moreover, domain 2 can bind the N-acetylgalactosamine 
(GalNAc), while this binding cannot occur in domain 1 due to steric hindrance (Rutenber and 
Robertus, 1991). Although the three-dimensional structures of the B chains are very similar, 
the main differences are observed in the amino acid residues that are present in the binding 
site, especially Tyr248 in 2γ of domain 2. The presence of a positive charge in this domain 
causes a loss of functionality because the hydrophobic interaction between the pyranose ring 
of galactose and the aromatic ring of Tyr is lost (Van Damme et al., 2000). X-ray 
crystallography studies of ebulin l (a non-toxic type 2 RIP) revealed changes in key amino 
acids within the sugar-binding 2γ subdomain. These changes reduce the affinity of ebulin l for 
galactosides and, therefore, for galactose-containing glycoproteins or glycolipids of the 
plasma membrane surface, thus reducing the cytotoxicity of the molecule (Ferreras et al., 
2010). Based on these studies, the carbohydrate-binding properties play an important role in 
the cytotoxicity of double chain RIPs. 
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AIM OF THE PROJECT 
Among all plant toxins, the most potent is a type 2 RIP purified from the caudex of the 
Passifloraceae Adenia stenodactyla, (stenodactylin). This RIP has a high enzymatic activity 
toward ribosomes and hsDNA substrates and a median lethal dose (LD50) for mice of 2.76 
µg/kg at 48 h (Stirpe et al., 2007). Moreover, similar to modeccin and volkensin (Wiley and 
Kline, 2000), stenodactylin is retrogradely transported when injected into the central nervous 
system (Monti et al., 2007). 
Currently, little is known about stenodactylin at the protein sequence level. Only the first 22 
and 21 amino acid residues of the A and B chains have been determined using direct Edman 
degradation. A protein sequence alignment between stenodactylin, modeccin (A. digitata), 
lanceolin A1, lanceolin A2 (A. lanceolata) and volkensin (A. volkensii) showed that the A 
chain of stenodactylin shares 21/21 identity with lanceolin A2 and 15/21 with volkensin (Fig. 
3.1). The identity among the B chains is also very high, except for the first three N-terminal 
residues; the sequence DPV is present only in the stenodactylin and volkensin B chains 
(Stirpe et al., 2007). 
 
 
 
 
 
 
 
 
 
Fig. 3.1. Amino acid alignment of the N-termini of lanceolin, stenodactylin, modeccin and volkensin subunits. 
The single letter code has been used for amino acids. Identical residues (*), conserved substitutions (:) and semi-
conserved (.) substitutions are reported. X, unassigned amino acid positions. 
Through a collaboration between our laboratory and Falini and co-workers, stenodactylin was 
crystallized, and crystal was tested using X-ray diffraction experiments. Figure 3.2 shows the 
crystal and the typical diffraction pattern of stenodactylin (Tosi et al., 2009). 
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Fig. 3.2. Crystal of stenodactylin (A) and X-ray diffraction (B) (Tosi et al., 2009). 
The purpose of this project was to determined the complete amino acid sequence of 
stenodactylin. The DNA sequence was determined using three different primers pairs that 
were designed based on the first 20 amino acids known for the A and B chains and the 
volkensin sequence. The volkensin sequence was chosen because both RIPs derive from 
plants belonging to the same genus and because the two RIPs show high sequence identity in 
the first 20 amino acids, as previously reported (Stirpe et al., 2007). 
The sequence of stenodactylin was aligned and compared with the sequences of other RIPs, 
including both type 2 (toxic and non-toxic) and type 1. 
The alignment and comparison is important (i) to identify both conserved and non-conserved 
amino acids, (ii) to understand the degree of evolutionary change and (iii) to detect amino 
acids that are important for their enzymatic activity. Stenodactylin is the most toxic RIP, and 
comparing its sequence with that of others less toxic RIPs (e.g., ricin) could provide useful 
information about which amino acids are directly or indirectly involved in their toxicity. The 
correlation between amino acids and cytotoxicity can be further studied through site-directed 
mutagenesis.  
The one-dimensional amino acid sequence of stenodactylin, together with the already 
published crystallographic analysis, will be used to determinate the three-dimensional 
structure.  
The three-dimensional structure is essential in understanding the protein function and the 
relationship between structure and cytotoxicity. Particularly, the structure appears to be 
important for some chemical-physical characteristics, such as the hydrophobic profile and the 
distribution of electrostatic charges particularly in domains that are near the catalytic site. 
Changes in these domains or in the catalytic site could explain the different biological 
A) B) 
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behavior of RIPs. Analyzing the tertiary structures can indicate the orientation and the 
position of amino acids that are involved in binding sugar. The ability of RIPs to bind to 
glycoprotein receptors seems to correlate with their cytotoxic properties. Binding occurs prior 
to internalization and intracellular transport; thus, reduced binding ability or binding to 
distinct receptors could lead to distinct intracellular pathways, which could cause different 
cytotoxic effects.  
RIPs are used to construct immunotoxins, which have been utilized for several clinical 
applications (mainly in hematological neoplasias). However, their application is currently 
limited because immunotoxins present several problems: formation of antibodies against the 
carrier and the RIP, capillary leak syndrome and hepatotoxicity. The ability to manipulate the 
protein structure and function is crucial to design more specific and less immunogenic 
immunotoxins. 
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RESULTS AND DISCUSSION 
3.1 Stenodactylin amino acid sequence 
3.1.1 Amplification and cloning of the stenodactylin gene 
Based on of the N-terminal amino acid sequences of the A and B chains of stenodactylin 
obtained in our laboratory by Edman degradation and based on the amino acid sequence of 
volkensin, primers were designed for the PCR amplification of A. stenodactyla genomic 
DNA. Using the volkensin sequence information available in GenBank (CAD61022), five 
specific primers were designed for the stenodactylin sequence.   
3.1.1.1 Isolation of the Amplicons 
The three primer pairs were used to amplify the A chain, the A chain with part of the B chain 
and the B chain of stenodactylin. As reported in Figure 3.3, the amplicons of expected size (~ 
0.85 kb for the A and B chains alone and ~ 1.1kb for the combined A and small segment of B 
chains) were obtained, and the PCR products were purified as described in the materials and 
methods. 
 
   A)                                        1         B)                 2           C)                                3 
 
 
 
 
 
 
 
Fig. 3.3. Amplification of stenodactylin A-chain (A, lane 1), A-chain and a part of B-chain (B, lane 2), B-chain 
(C, lane 3). MW: λ Hind III/EcoRI double digest DNA marker. The red circles are to indicate the amplificate. 
3.1.1.2 Ligation and confirmation of recombinants 
The three purified fragments were ligated into the pCR®II vector and then transferred into 
E.coli INVαF'. Because the vector contained genes for ampicillin-resistance, only bacteria 
with the vector grew on agar plates containing ampicillin.  
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The transformed white colonies were picked for plasmid isolation and restriction analysis. 
The fraction of the transformants that were positive for the presence of the fragment of the A 
chain, the combined A and small segment of B chains, and the B chain were 8/8, 2/12 and 
4/16, respectively. Two clones for each fragment were purified and sequenced using M13 
primers.   
3.2 Sequence analysis  
The fragments corresponding to the stenodactylin gene ends presented a homologous 
overlapping region. The sequence information was analyzed using the algorithms available at 
http://expasy.org. The full-length caudex cDNA sequence analysis revealed that stenodactylin 
is encoded by a 1572-bp open reading frame (ORF) that encoded a polypeptide of 524 amino 
acids (Fig. 3.4). Only the first 11 amino acids were obtained only by Edman degradation. 
The gene contains 753 bp that encode the A chain (251 amino acid residues with a calculated 
Mr of 28,420.38) and 771 bp that encode the B chain (267 amino acid residues with a 
calculated Mr of 28,468.32) separated by an internal linker sequence of 45 bp (between the 
amino acids 252 and 266). The probable C-terminal end of the A chain and the linker 
sequence were estimated based on the homology with the volkensin gene. Stenodactylin 
contains a total of 13 cysteine residues. The A chain includes Cys9, Cys157 and the C-terminal 
Cys246, which is involved in the intermolecular disulfide bond. The B chain includes 12 
cysteines (Cys270, Cys286, Cys305, Cys329, Cys344, Cys415, Cys428, Cys454, Cys472, Cys457, 
Cys461), eight of which (Cys286-Cys305, Cys329-Cys344, Cys415-Cys428, and Cys454-Cys472) form 
conserved intramolecular disulfide bridges; one cysteine (270) at the N-terminal binds to the 
A chain. The amino acid residues that are important for the enzymatic activity of RIPs were 
conserved within the sequence of the A chain of stenodactylin (Tyr74, Tyr113, Glu163, Arg166, 
and Trp200). In addition, based on the online program NetNGlyc1.0, two possible 
glycosylation sites were detected at position Asn359-Gly360-Thr361 and Asn399-Val400-Thr401. 
The sugar presence could explain the difference between the molecular weight of the B chain 
based on the amino acid sequence (28 kDa) and the molecular weight observed by 
electrophoretic mobility (32 kDa). As reported for other type 2 RIPs, the A chain of 
stenodactylin contains only two lysines (of the 251 amino acids that comprise the A chain). 
Lysine residues are potential ubiquitination sites, and the small number of lysines is important 
to avoid ubiquitination and subsequent degradation (Deeks, et al., 2002).  
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Fig. 3.4. Full length sequence and derived amino acid sequence of the stenodactylin gene. The A chain is 
presented in black, the B chain is presented in blue and the sequence of the linker peptides is presented in red. 
The amino acids involved in the catalytically active center of the A-chain are underlined. 
nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnngccacggtagagaggtacactcagttt   60 
 V  F  P  K  V  I  F  D  C  T  R  A  T  V  E  R  Y  T  Q  F    20 
ataatgctcttaaggaacgaactggcgggtgatgtttctccacagggaatacgcaggctg  120 
 I  M  L  L  R  N  E  L  A  G  D  V  S  P  Q  G  I  R  R  L    40 
aggaatccggctgatattcagcctacacagcgttttattcttatacaactcaacggcttc  180 
 R  N  P  A  D  I  Q  P  T  Q  R  F  I  L  I  Q  L  N  G  F    60 
gtaagctccgtcaccttgataatggacgtcagcaatgcgtatctattgggttatgagagc  240 
 V  S  S  V  T  L  I  M  D  V  S  N  A  Y  L  L  G  Y  E  S    80 
cgcaactttgtgtatcacttcaacgatgtctctacctcttcgatcgccgatgttttccca  300 
 R  N  F  V  Y  H  F  N  D  V  S  T  S  S  I  A  D  V  F  P   100 
gacgtacaacgtcaacagttgccatttgaaggcggctatcccagcatgcgacactatgcg  360 
 D  V  Q  R  Q  Q  L  P  F  E  G  G  Y  P  S  M  R  H  Y  A   120 
ccggagagagatcaaattgaccatggattcatcgaactggcatacgctgttgatacgctc  420 
 P  E  R  D  Q  I  D  H  G  F  I  E  L  A  Y  A  V  D  T  L   140 
tactatagtagtcaaggctacgaacagatcgcgcgttcactcgtgctctgcgccgggatg  480 
 Y  Y  S  S  Q  G  Y  E  Q  I  A  R  S  L  V  L  C  A  G  M   160 
gttgcagaagccgcccggttccgctacatcgaggggctagtgcgtcaaagcattgtcggg  540 
 V  A  E  A  A  R  F  R  Y  I  E  G  L  V  R  Q  S  I  V  G   180 
ccaggagactacggaactttcagaccggatgcgttgatgtactcagtcgtgacagcgtgg  600 
 P  G  D  Y  G  T  F  R  P  D  A  L  M  Y  S  V  V  T  A  W   200 
cagactctttcagaaagaatccagggatccttcgacggagctttccagccagttcagctg  660 
 Q  T  L  S  E  R  I  Q  G  S  F  D  G  A  F  Q  P  V  Q  L   220 
gggtatgccagcgatcccttttattgggacaacgtcgcacaggccatcaccaggctgtca  720 
 G  Y  A  S  D  P  F  Y  W  D  N  V  A  Q  A  I  T  R  L  S   240 
ctcatgctattcgcctgcgctaaacctccaaggcaatccgattccctcatggtgataagg  780 
 L  M  L  F  A  C  A  K  P  P  R  Q  S  D  S  L  M  V  I  R   260 
tcctttgtggataggaacgatcctgtctgcccttccggggagacgactgcgtacatcgtg  840 
 S  F  V  D  R  N  D  P  V  C  P  S  G  E  T  T  A  Y  I  V   280 
gggcgggacgggcgctgtgtggacgtgaaggatgaggaattcttcgacggcaataaagta  900 
 G  R  D  G  R  C  V  D  V  K  D  E  E  F  F  D  G  N  K  V   300 
cagatgtggccgtgcaagtccagccagaatgcaaaccagctgtggactataaagagagac  960 
 Q  M  W  P  C  K  S  S  Q  N  A  N  Q  L  W  T  I  K  R  D   320 
ggcactattcggtgcaagggaaagtgcttgactgtgaggagcccgcaactgtacgctatg 1020 
 G  T  I  R  C  K  G  K  C  L  T  V  R  S  P  Q  L  Y  A  M   340 
atctgggactgcaccactttttatgctcctgccaccaagtgggaagtgtgggacaacggg 1080 
 I  W  D  C  T  T  F  Y  A  P  A  T  K  W  E  V  W  D  N  G   360 
accatcatcaaccccgcctccgggggggtgttgaccgcgcccactggggacgcgggcgtc 1140 
 T  I  I  N  P  A  S  G  G  V  L  T  A  P  T  G  D  A  G  V   380 
atcctcagcctggagctcaacgagtacgccgctagccaggcgtggagggtgaccaatgtg 1200 
 I  L  S  L  E  L  N  E  Y  A  A  S  Q  A  W  R  V  T  N  V   400 
acagtacctacggtggcaaccattgtgggatatgatgatctctgcctggaaaccaacgac 1260 
 T  V  P  T  V  A  T  I  V  G  Y  D  D  L  C  L  E  T  N  D   420 
aacaatgtatggttggtcaactgcgtgaaaggcaagacgcaacagagatgggcgcagtat 1320 
 N  N  V  W  L  V  N  C  V  K  G  K  T  Q  Q  R  W  A  Q  Y   440 
gcggatggcaccatacgctcccagtccagcctcagcaaatgcctcacctgcagtggcgac 1380 
 A  D  G  T  I  R  S  Q  S  S  L  S  K  C  L  T  C  S  G  D   460 
tgcgtcaagctggcaaagatcgtcaacacggactgtgctggatccgccttgagccgttgg 1440 
 C  V  K  L  A  K  I  V  N  T  D  C  A  G  S  A  L  S  R  W   480 
tacttcaacacctatggcggcatcgtgaatctgttgaccggcatggtgatggacgtgaaa 1500 
 Y  F  N  T  Y  G  G  I  V  N  L  L  T  G  M  V  M  D  V  K   500 
gagtccaatccgagtctcaacgaaataattgcccacccgtggcatggaaactccaaccag 1560 
 E  S  N  P  S  L  N  E  I  I  A  H  P  W  H  G  N  S  N  Q   520 
caatggttccta 1572  
 Q  W  F  L   524 
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Based on the amino acid sequence, the secondary structure was predicted by the highly 
accurate PSIPRED algorithm for protein secondary structure prediction. The 524 amino acid-
long protein was calculated to have 24% extended strands, 24% α- helixes and 52% random 
coils, with α- helix structures only present in the A chain (Fig. 3.5). 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A chain 
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           B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.5. Secondary structure analysis of stenodactylin A chain (A) and B chain (B). The secondary structure 
motifs was predicted using the PSIPRED Protein Structure Prediction Server. The predicted -helix and -sheet 
structure elements and randomly structured coil regions of the target sequences are displayed according to the 
symbols shown in the legend. The confidence levels of the prediction are reported in the figure. 
B chain 
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The stenodactylin polypeptide sequence was aligned with volkensin using the Clustal W 
software. A comparison of the amino acid sequence of stenodactylin with volkensin showed 
86.1% amino acid identity (Fig. 3.6). This homology was not surprising because these two 
RIPs were purified from plants belonging to the same genus (Adenia). The results show 
higher identity between the B chains (90.3%) than between the A chains (81.7%). In addition, 
the A chain of stenodactylin contains one more cysteine at position 9 compared with 
volkensin. The same additional cysteine was observed in lanceolin, but its role remains 
unclear (Stirpe, et al., 2007). The B chains of both stenodactylin and volkensin contain 12 
cysteine residues. The catalytic key residues that are involved in the enzymatic mechanism 
and the 12 amino acids that are involved in the active center of the A chain (amino acids from 
158 to 174 in stenodactylin) are almost conserved, except for Ala165 in stenodactylin, which is 
replaced with Ser164 in volkensin.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.6. Alignment between stenodactylin and volkensin (GenBank CAD61022). Identical residues (*), conserved 
substitutions (:) and semiconserved substitutions (.) are reported. The A and B chains are presented in black; the 
sequence of the linker peptides is presented in gray. The amino acids that are involved in the catalytically active 
center of the A chain are underlined, while the ones involved in the enzymatic mechanism are high-lighted in gray. 
Cysteine residues are high-lighted in yellow. The dash indicates a gap introduced into the sequences to maximize 
alignments. 
VOLKENSIN     VFPKVPFDVPKATVESYTRFIRVLRDELAGGVSPQGIRRLRNPAEIQPSQGFILIQLTGY 60 
STENODACTYLIN VFPKVIFDCTRATVERYTQFIMLLRNELAGDVSPQGIRRLRNPADIQPTQRFILIQLNGF 60 
              ***** **  :**** **:** :**:**** *************:***:* ******.*: 
 
VOLKENSIN     VGSVTLIMDVRNAYLLGYLSHNVLYHFNDVSASSIASVFPDAQRRQLPFGGGYPSMRNYA 120 
STENODACTYLIN VSSVTLIMDVSNAYLLGYESRNFVYHFNDVSTSSIADVFPDVQRQQLPFEGGYPSMRHYA 120 
              *.******** ******* *:*.:*******:****.****.**:**** *******.** 
 
VOLKENSIN     PERDQIDHGIVELAYAVDRLYYSQ-NNNQIALGLVICAGMVAEASRFRYIEGLVRQSIVG 179 
STENODACTYLIN PERDQIDHGFIELAYAVDTLYYSSQGYEQIARSLVLCAGMVAEAARFRYIEGLVRQSIVG 180 
              *********::******* ****.   :*** .**:********:*************** 
 
VOLKENSIN     PGDYRTFRPDALMYSIVTQWQTLSERIQGSFNGAFQPVQLGYASDPFYWDNVAQAITRLS 239 
STENODACTYLIN PGDYGTFRPDALMYSVVTAWQTLSERIQGSFDGAFQPVQLGYASDPFYWDNVAQAITRLS 240 
              **** **********:** ************:**************************** 
 
VOLKENSIN     LMLFVCSQPPRQSDSPLVIRSFVDRNDPVCPSGETTAFIVGRDGRCVDVKVEEFFDGNKV 299 
STENODACTYLIN LMLFACAKPPRQSDSLMVIRSFVDRNDPVCPSGETTAYIVGRDGRCVDVKDEEFFDGNKV 300 
              ****.*::******* :********************:************ ********* 
 
VOLKENSIN     QMWPCKSSQNANQLWTLKRDGTIRCQGKCLTVRSPQLYAMIWDCTTFYAPATKWEVWDNG 359 
STENODACTYLIN QMWPCKSSQNANQLWTIKRDGTIRCKGKCLTVRSPQLYAMIWDCTTFYAPATKWEVWDNG 360 
              ****************:********:********************************** 
VOLKENSIN     TIINPASGRVLTAPTGEAGVTLNLQFNEYAASQAWRVTNVTVPTVTTIVGYDDLCLETNG 419 
STENODACTYLIN TIINPASGGVLTAPTGDAGVILSLELNEYAASQAWRVTNVTVPTVATIVGYDDLCLETND 420 
              ******** *******:*** *.*::*******************:*************  
 
VOLKENSIN     NGVWLANCVKGKAQQRWTLYADGTIRSQSTLSKCLACSGSCVKLAKIVNTDCAGSANSRW 479 
STENODACTYLIN NNVWLVNCVKGKTQQRWAQYADGTIRSQSSLSKCLTCSGDCVKLAKIVNTDCAGSALSRW 480 
              * ***.******:****: **********:*****:***.**************** *** 
 
VOLKENSIN     YFDNYGGIVNLRTGMVMDVKESNPSLNEIIAHPWHGNSNQQWFL 523 
STENODACTYLIN YFNTYGGIVNLLTGMVMDVKESNPSLNEIIAHPWHGNSNQQWFL 524 
              **:.******* ******************************** 
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Figure 3.7 shows a 3D model of stenodactylin (A) and volkensin (B). The three-dimensional 
structures were predicted using the 3D structure template of cinnamomin (isoform III) using 
the online Swiss model program. Both structures are similar, and the B chain of stenodactylin 
is composed of two subdomains that contain short strands of β-sheets and turns and loops, as 
found in other type 2 RIPs. 
               (A)                                                     Stenodactylin 
 
 
 
 
 
 
 
      
           (B)                                                            Volkensin 
 
 
 
 
 
 
 
Fig. 3.7. 3D model of stenodactylin (A) and volkensin (B) predicted by Swiss-model protein structure prediction 
server. The A chain is presented  in blue, and the B chain is presented in green and orange.  
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3.3 Sequence comparison between stenodactylin and other RIPs 
3.3.1 Sequence comparison with type 2 RIPs 
The amino acid sequence of stenodactylin was aligned with the amino acid sequences of toxic 
type 2 RIPs (e.g., volkensin, ricin, abrin, viscumin, riproximin) and non-toxic (e.g., 
cinnamomin, ebulin l and nigrin b) that have been reported in GenBank (Fig. 3.8). The 
multiple alignment analysis showed that in all RIP B chains contain eight cysteine residues 
that are involved in four conserved intramolecular disulfide bridges and the B chain N-
terminal cysteine that forms the intermolecular disulfide bridge between the A and B chains. 
Furthermore, the catalytic key residues (Tyr74, Tyr113, Glu163, Arg166, Trp200 in stenodactylin) 
that are involved in the enzymatic mechanism are conserved in all A chains of the RIPs.   
Crystallographic studies of ricin showed that the B chain folds into two similar globular 
domains. Each of these domains is composed of three subdomains (1α, 1β and 1γ for domain 
1 and 2α, 2β and 2γ for domain 2). Only two of these subdomains, 1α and 2γ, bind to 
galactoside. The amino acids involved in the 1α binding site of ricin are Asp337, Gln350, Trp352, 
Asn361 and Gln362, while the ones constituting the 2γ binding site are Asp549, Ile561, Tyr563, 
Asn570, Gln571 (Rutenber and Robertus., 1991). Analysis of stenodactylin and all the other 
considered RIPs showed that all the amino acids that are involved in the first binding site of 
ricin are fully conserved, although Gln350 is replaced by Ile302 in abrin. In the 2γ binding site 
of stenodactylin, only one amino acid is changed compared with ricin; Tyr563 is replaced with 
His512  in stenodactylin. The same substitution was observed in volkensin (Chambery et al., 
2004), R. communis agglutinin (RCA) (Roberts et al., 1985) and P.multiflorum (PMRIPm) 
(Van Damme et al., 2000). Site-directed mutagenesis studies on the ricin B chain 
demonstrated that the replacement of Tyr248 with His248 reduced its binding activity (Lehar et 
al., 1994). 
The presence of a positive charge within the 2γ binding site prevents the hydrophobic 
interaction between the pyranose ring of galactose and the aromatic ring of Tyr; this 
substitution reduced functionality (Van Damme et al., 2000). Cinnamomin contains two 
substitutions in the 2γ binding site compared with ricin (Trp537 for Tyr537and His543 for 
Gln535). While the first substitution was between two aromatic amino acids, the second one 
introduces a positive charge. 
Because the lectin activity requires strictly conserved amino acids in both the 1α and 2γ 
domains, their change may explain the reduced cytotoxicity of cinnamonin (Wang et al., 
2006). In addition, Tyr537 in ricin is replaced with Phe522 in ebulin l. This substitution 
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indicates to alters the binding of galactosides and may reduce the cytotoxicity of ebulin l 
(Pascal et al., 2001).  
All these data suggest that the 2γ binding site is important for the toxicity of RIPs, and any 
changes in this site could affect RIP binding. However, this hypothesis does not correlate with 
the results obtained with stenodactylin. In contrast, stenodactylin, which showed a change in 
this subdomain, is one of the most toxic RIPs.  
 
Stenodactylin ----VFPKVIF-DCTRATVERYTQFIMLLRNELAGDVS-PQGIRRLRNP-ADIQPTQRFILIQLNGFV--SSVTLIMDVSNAYLLGYESRNFVYHFNDVSTSSI 95 
Volkensin     ----VFPKVPF-DVPKATVESYTRFIRVLRDELAGGVS-PQGIRRLRNP-AEIQPSQGFILIQLTGYV--GSVTLIMDVRNAYLLGYLSHNVLYHFNDVSASSI 95 
Ricin         IFPKQYPIINF-TTAGATVQSYTNFIRAVRGRLTTGADVRHEIPVLPNR-VGLPINQRFILVELSNHA-ELSVTLALDVTNAYVVGYRAGNSAYFFHPDNQEDA 101 
Abrin a       ----QDRPIKF-STEGATSQSYKQFIEALRERLRGGL--IHDIPVLPDP-TTLQERNRYITVELSNSD-TESIEVGIDVTNAYVVAYRAGTQSYFLRDAPSSAS 95 
Cinnamomin    -----YQTVTF-TTKKATKTSYTQFIEALRAQLASGEE-PHGIPVMRER-STVPDSKRFILVELSNWAADSPVTLAVDVTNAYVVAYRTGSQSFFLREDNPDPA 96 
Viscumin      -----YERLRLRVTHQTTGEEYFRFITLLRDYVSSGSF-SNEIPLLRQSTIPVSDAQRFVLVELTNEG-GDSITAAIDVTNLYVVAYQAGDQSYFLRDAPRGAE 97 
Riproximin    ---IDYPTFRL-SLSGLTQRDYNQFVRDLRDRLARHNDRRHGVPVLRQP-GXVLENERFILVELTNMAEDXTMTWAIDVTNLYLVGYQVGBRSYFFRGXPEEAT 99 
Ebulin        ---IDYPSVSF-NLAGAKSTTYRDFLKNLRDRVATGTYEVNGLPVLRRE-SEVQVKNRFVLVRLTNYN-GDTVTSAVDVTNLYLVAFSANGNSYFFKDATELQK 98 
Nigrin b      ---IDYPSVSF-NLDGAKSATYRDFLSNLRKTVATGTYEVNGLPVLRRE-SEVQVKSRFVLVPLTNYN-GNTVTLAVDVTNLYVVAFSGNANSYFFKDATEVQK 98 
                      . :      .   *  *:  :*  :       . :  :      :   . :: : *.       :   :** * *::.:      :.:.                      
 
Stenodactylin ----ADVFPDVQRQQLPFEGGYPSMRHYAPE--RDQIDHGFIELAYAVDTLYYSS------QGYEQIARSLVLCAGMVAEAARFRYIEGLVRQSIVGPGDYGTF 187 
Volkensin     ----ASVFPDAQRRQLPFGGGYPSMRNYAPE--RDQIDHGIVELAYAVDRLYYSQ-------NNNQIALGLVICAGMVAEASRFRYIEGLVRQSIVGPGDYRTF 186 
Ricin         EAITHLFTDVQNRYTFAFGGNYDRLEQLAGNL-RENIELGNGPLEEAISALYYYSTGG---TQLPTLARSFIICIQMISEAARFQYIEGEMRTRIRYN---RRS 198 
Abrin a       ---D-YLFTGTDQHSLPFYGTYGDLERWAHQS-RQQIPLGLQALTHGIS---FFRSGG---NDNEEKARTLIVIIQMVAEAARFRYISNRVRVSIQTG---TAF 185 
Cinnamomin    --IENLL-PDTKRYTFPFSGSYTDLEGVAGER-REEILLGMDPLENAISALWISNL-----NQQRALARSLIVVIQMVAEAVRFRFIEYRVRGSISRA---EMF 188 
Viscumin      ----THLFTGTTRSSLPFNGSYPDLERYAGH--RDQIPLGIDQLIQSVTALRF---PG---GSTRTQARSILILIQMISEAARFNPILWRARQYINSG---ASF 186 
Riproximin    ----RNLFXDTTXQSYDFTGDYTQLRPRAGVGNIDSITLGFNQLDESINYLFRHSGQXHTEEEKNKQATAMIVCIVMIAEAVRFRYIQGTLAGTIIGDGRYRSF 199 
Ebulin        ----SNLFLGTTQHTLSFTGNYDNLETAAGTR-RESIELGPNPLDGAITSLWYDG----------GVARSLLVLIQMVPEAARFRYIEQEVRRSLQQL---TSF 184 
Nigrin b      ----SNLFVGTKQNTLSFTGNYDNLETAANTR-RESIELGPSPLDGAITSLYHGD----------SVARSLLVVIQMVSEAARFRYIEQEVRRSLQQA---TSF 184 
                    .          * * *  :.  *     :.*  *   *  .:                   *  :::   *: ** **. *       :                  
 
Stenodactylin RPDALMYSVVTAWQTLSERIQGSFDGA---FQPVQLGYA-SDPFYWDNVA--QAITRLSLMLFACAKPPRQS-----DSLMVIRSFVDR---------NDPVCP 271 
Volkensin     RPDALMYSIVTQWQTLSERIQGSFNGA---FQPVQLGYA-SDPFYWDNVA--QAITRLSLMLFVCSQPPRQS-----DSPLVIRSFVDR---------NDPVCP 270 
Ricin         APDPSVITLENSWGRLSTAIQESNQGA--FASPIQLQRRNGSKFSVYDV-S-ILIPIIALMVYRCAPPPSS------QFSLLIRPVVP--------NFNADVCM 284 
Abrin a       QPDAAMISLENNWDNLSRGVQESVQDT--FPNQVTLTNIRNEPVIVDSLSH-PTVAVLALMLFVCNPPNANQ------SPLLIRSIVEKS---------KICSS 271 
Cinnamomin    RPDPAMLSLENKWSALSNAVQQSNQGG-VFSSPVELRSISNKPVYVGSVSD-RVISGLAIMLFICRSTDRASSDQFIDHMLMIRPILVDVAEVATDADNDDTCA 290 
Viscumin      LPDVYMLELETSWGQQSTQVQQSTDGV--FNNPIRLAIPPGNFVTLTNV-R-DVIASLAIMLFVCGERPSSSDVR--YWPLVIRPVIAD----------DVTCS 274 
Riproximin    NNNGAVARFINTWQDLSQAIQESNEDG-VFPNQIRLQSPTYAEYWATNVMP-NLVAAIGIMXYFCAKPPPPXSVA------------------STVGYNGQXCA 283 
Ebulin        TPNALMLSMENNWSSMSLEVQLSGDNVSPFSGTVQLQNYDHTPRLVDNFEELYKITGIAILLFRCVATKTTHNAI--RMPHVL------VGEDNKFN-DGETCA 279 
Nigrin b      TPNALMLSMENNWSSMSLEIQQAGNNVSPFFGTVQLLNYDHTHRLVDNFEELYKITGIAILLFRCSSP-SNDNAI--RMPLDL------AGEDNKYN-DGETCT 278 
                :  :  . . *   *  :* : :        : *           ..     :  :.:: : *                                     . 
 
Stenodactylin SGE-TTAYIVGRDGRCVDVKDEEFFDGNKVQMWPCKSSQNANQLWTIKR-GTIRCKGKCLTVR----SPQLYAMIWDCTTFYAPATKWEVWDNGTIINPASGGV 369 
Volkensin     SGE-TTAFIVGRDGRCVDVKVEEFFDGNKVQMWPCKSSQNANQLWTLKRDGTIRCQGKCLTVR----SPQLYAMIWDCTTFYAPATKWEVWDNGTIINPASGRV 368  
Ricin         DPE-PIVRIVGRNGLCVDVRDGRFHNGNAIQLWPCKSNTDANQLWTLKRDNTIRSNGKCLTTY--GYSPGVYVMIYDCNTAATDATRWQIWDNGTIINPRSSLV 385 
Abrin a       RYE-PTVRIGGRDGMCVDVYDNGYHNGNRIIMWKCKDRLEENQLWTLKSDKTIRSNGKCLTTY--GYAPGSYVMIYDCTSAVAEATYWEIWDNGTIINPKSALV 372 
Cinnamomin    DPE-PTVRISGRNGLCVDVRDGKYNNGNPIQLWPCKQNSDVNQLWTLRRDGAIRSNGKCLTTN--GYSAGDYVMIYDCRTPVTAASIWQFWANGTIINPQSALV 391 
Viscumin      ASE-PTVRIVGRNGMCVDVRDDDFHDGNQIQLWPSKSNNDPNQLWTIKRDGTIRSNGSCLTTY--GYTAGVYVMIFDCNTAVREATLWEIWGNGTIINPRSNLV 375 
Riproximin    DPQ-PTVRISGRDGKCADVKGGYYNDGDPIILWPCKSNTDANQLWILKKDGTIRSKGKCLSTSFGRYHFISTVMIYDCSIATKAATRWKVWDNGTIINSASSLV 386 
Ebulin        IPAPFTRRIVGRDGLCVDVRNGYDTDGTPIQLWPCGT--QRNQQWTFYNDKTIRSMGKCMTAN--GLNSGSYIMITDCSTAAEDATKWEVLIDGSIINPSSGLV 379 
Nigrin b      LRTSFTRNIVGRDGLCVDVRNGYDTDGTPLQLWPCGT--QRNQRWTFDSDDTIRSMGKCMTAN--GLNNGSNIVIFNCSTAAENAIKWEVPIDGSIINPSSGLV 378 
                      * **:* *.**      :*  : :* .    : ** * :    :**. *.*::.           :* :*      *  *:.  :*:***  *  * 
 
Stenodactylin LTAPTGDAGVILSLELNEYAASQAWRVTNVTVPTVA-TIVGYDDLCLETND--NNVWLVNCVKGKTQQRWAQYADGTIRSQSSLS--KCLTCSGDCV--KLAKI 466 
Volkensin     LTAPTGEAGVTLNLQFNEYAASQAWRVTNVTVPTVT-TIVGYDDLCLETNG--NGVWLANCVKGKAQQRWTLYADGTIRSQSTLS--KCLACSGSCV--KLAKI 465 
Ricin         LAATSGNSGTTLTVQTNIYAVSQGWLPTNNTQPFVT-TIVGLYGLCLQANS--GQVWIEDCSSEKAEQQWALYADGSIRPQQNRD--NCLTSDSNI---RETVV 481 
Abrin a       LSAESSSMGGTLTVQTNEYLMRQGWRTGNNTSPFVT-SISGYSDLCMQAQG--SNVWMADCDSNKKEQQWALYTDGSIRSVQNTN--NCLTSKDHK---QGSTI 470 
Cinnamomin    LSAESGNPRTTLTVQANIYASRQGWLAGNNTEPFVT-SIVGFNDLCMQANG--DAMWVEECESSKAEQKWALYPDGSIRPHQDPGPAACPLLDNHP---QGSII 489 
Viscumin      LAASSGIKGTTLTVQTLDYTLGQGWLAGNDTAPREV-TIYGFRDLCMESNG--GSVWVETCVISQQNQRWALYGDGSIRPKQNQD--QCLTCGRDS---VSTVI 471 
Riproximin    LTXELGTSGTPLTVRANSYSTSQSWLPSNFSEPFVVSSILGLKDLCLQATG--NGVWLEQCVTNKAEQKWALFPDRSIRPYSDRD--LCLSCNTDETSHQLNIV 486 
Ebulin        MTAPSGASRTTLLLENNIHAASQGWTVSNDVQPIAT-LIVGYNEMCLQANGENNNVWMEDCDVTSVQQQWALFDDRTIRVNNSRG--LCVTSNGYV---SKDLI 477 
Nigrin b      MTAPRAASRTILLLEDNIYAASQGWTVTNNVKPIVA-SIVGYKEMCLQSNGENNGVWMEDCEATSLQQQWALYGDRTIRVNSTRG--LCVTTNGYN---SKDLI 476 
              ::            .   :   *.*   *   *  .  * *   :*:::      :*:  *   . :*:*: : * :**  .      *              :   
 
 
Stenodactylin VNTDC-AGSALSRWYFNTYGGIVNLLTGMVMDVKESNPSLNEIIAHPWHGNSNQQWFL----- 524  
Volkensin     VNTDC-AGSANSRWYFDNYGGIVNLRTGMVMDVKESNPSLNEIIAHPWHGNSNQQWFL----- 523  
Ricin         KILSCGPASSGQRWMFKNDGTILNLYSGLVLDVRASDPSLKQIILYPLHGDPNQIWLPLF--- 541  
Abrin a       LLMGCSNGWASQRWVFKNDGSIYSLYDDMVMDVKGSDPSLKQIILWPYTGKPNQIWLTLF--- 528  
Cinnamomin    IISSCSPGSEGRRWVFMNDGTVLNLKNGLVMDVKGSNPSLHQIIIWPATGKPNHEWLPLL--- 549  
Viscumin      NIVSCSAGSSGQRWVFTNEGAILNLKNGLAMDVAQANPKLRRIIIYPATGKPNQMWLPVP--- 531  
Riproximin    NLLSCGSASPGQHWMFRNNGDVLNIYSGLVMDVKXSNPSLHQILAWPPNGGRNQKWMVVV--- 546  
Ebulin        VIRKC-QGLATQRWFFNSDGSVVNLKSTRVMDVKESDVSLQEVIIFPATGNPNQQWRTQVPQI 539  
Nigrin b      IILKC-QGLPSQRWFFNSDGAIVNPKSRHVMDVRASNVSLREIIIFPATGNPNQQWVTQVLPS 538  
                  *  .    :* * . * : .     .:**  :: .*..::  *  *  *: *        
 
 
Fig. 3.8. Protein sequence alignment of stenodactylin with volkensin (acc.no CAD61022), ricin (acc.no P02879), 
abrin a (acc.no P11140), cinnamomum (acc.no AAF68978), viscumin (acc.no P81446), riproximin (acc.no 
CAJ38823), ebulin l (acc.no CAC33178), nigrin b (acc.no P33183). Identical residues (*), conserved 
substitutions (:) and semiconserved substitutions (.) are reported. Cystein residues are high-lighted in yellow. 
The catalytic key residues are high-lighted in gray. The amino acid residues formed the carbohydrate-binding 
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site are high-lighted in light blue. The position of the intramolecular and intermolecular disulfide bonds are 
indicated by solid and dashed lines. Dashes denote gaps introduced to obtain maximal homology. 
Table 3.1 demonstrates the identity between stenodactylin with toxic and non-toxic type 2 
RIPs. The results show that there is a high percentage of identity between the A chains of 
stenodactylin and volkensin. All other identities were lower, ranging from 27.7 to 31.4%. 
As reported in the literature (Barbieri et al., 1993), a high degree of identity was detected 
when the B chain was compared with other B chains (90.3% with volkensin and ranging from 
42.1 to 47.7% with the other RIPs). These data support the hypothesis that the B chain is a 
product of a gene duplication event (Villafranca and Robertus, 1981). 
Table 3.1. Identity of eight type 2 RIP A-chains, B-chains and whole RIP with stenodactylin. 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 Sequence comparison with type 1 RIPs 
The sequence of stenodactylin was aligned with saporin, dianthin and momordin using Clustal 
W software and the type 1 RIP amino acid sequences reported in GenBank (Fig. 3.9). The 
amino acid residues that are important in the active site of the RIPs (Tyr74, Tyr113, Glu163, 
Arg166 and Trp200 in stenodactylin) were conserved in all the four RIPs, while a strong 
difference was observed in the lysine residues. Stenodactylin only has two lysine residues, 
while saporin, dianthin and momordin contain 22, 19 and 10 lysine residues, respectively. 
Savino and co-workers reported that the saporin-6 sequence contains three lysines (220, 226, 
and 234) that are protected and are either conserved or replaced by positively charged or polar 
residues in other RIPs (Savino et al., 2000). These authors deduced that the region containing 
these lysine residues is important for the interaction with the ribosome. Moreover, in saporin 
 Identity (%) 
(stenodactylin) 
A chain 
Identity (%) 
(stenodactylin) 
B chain 
Identity (%) 
(stenodactylin) 
whole 
Volkensin 81.7 90.3 86.1 
Ricin 31.4 47.7 40.3 
Viscumin 31.0 46.0 38.1 
Abrin a 31.2 44.6 37.9 
Riproximin 27.7 43.3 35.8 
Cinnamomin 33.0 42.1 37.3 
Ebulin 28.7 44.2 36.5 
Nigrin b 29.0 43.9 36.5 
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and dianthin, the length of the loop containing the lysines is relatively short, thus providing 
better accessibility to the ribosome for both RIPs. In stenodactylin, these three lysines are 
replaced with Phe210, Ala223 and Asn231. Because Phe and Ala are nonpolar amino acids, we 
hypothesize that the molecular recognition of the ribosome involves other residues in 
stenodactylin. The comparison of the stenodactylin A chain sequence with type 1 RIPs 
showed a very low level of identity (Table 3.2). As above reported, the stenodactylin A chain 
showed a low degree of identity when compared with other type 2 RIPs A chains, with the 
exception of volkensin. Moreover, the identity of the A chains was lower than the identity of 
the B chains. The homology between the type 1 RIPs and the stenodactylin A chain was even 
lower than the identity calculated between the stenodactylin A chain and other type 2 RIPs A 
chains. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Fig. 3.9. Protein sequence alignment of stenodactylin with saporin (acc.no CAA41948,1), dianthin 30 (acc.no 
CAA41953,1), and momordin (P16094.2). Identical residues (*), conserved substitutions (:) and semiconserved 
substitutions (.) are reported. The dashes indicate gaps introduced into the sequences to maximise alignments. 
The catalytic key residue are high-lighted in gray. The saporin-6  lysines (220, 226 and 234) and the 
corresponding residues of other RIPs are high-lighted in yellow. 
 
Stenodactylin   VFPKVIFDCTRATVERYTQFIMLLRNELAGDVSPQGIRRLRNPADIQPTQRFILIQLNGF 60 
Momordin        ---DVSFRLSGADPRSYGMFIKDLRNALPFREKVYNIPLLL--PSVSGAGRYLLMHLFNY 55 
Saporin         -VTSITLDLVNPTAGQYSSFVDKIRNNVKDPNLKYGGTDIAVIGPPSK-EKFLRINFQSS 58 
Dianthin        -ATAYTLNLANPSASQYSSFLDQIRNNVRDTSLIYGGTDVAVIGAPSTTDKFLRLNFQGP 59 
                      :         *  *:  :** :           :      .   ::: :.: 
 
Stenodactylin   VS-SVTLIMDVSNAYLLGYESR-----NFVYHFNDVSTSSIAD-VFPDV--QRQ-QLPFE 110 
Momordin        DGKTITVALDVTNVYIMGYLAD-----TTSYFFNEPAAELASQYVFRDA--RRKITLPYS 108 
Saporin         RG-TVSLGLKRDNLYVVAYLAMDNTNVNRAYYFKSEITSAELTALFPEATTANQKALEYT 117 
Dianthin        RG-TVSLGLRRENLYVVAYLAMDNANVNRAYYFKNQITSAELTALFPEVVVANQKQLEYG 118 
                   :::: :   * *::.* :      .  *.*:.  :.     :* :.   .:  * : 
 
Stenodactylin   GGYPSMRHYA-----PE-RDQIDHGFIELAYAVDTLYYSSQGYEQIARSLVLCAGMVAEA 164 
Momordin        GNYERLQIAA-----GKPREKIPIGLPALDSAISTLLHYDS--TAAAGALLVLIQTTAEA 161 
Saporin         EDYQSIEKNAQITQGDKSRKELGLGIDLLLTFMEAVNKKARVVKNEARFLLIAIQMTAEV 177 
Dianthin        EDYQAIEKNAKITTGDQSRKELGLGINLLITMIDGVNKKVRVVKDEARFLLIAIQMTAEA 178 
                  *  :.  *        *.::  *:  *   :. :          *  *::    .**. 
 
 
 
Stenodactylin   ARFRYIEGLVRQSIVGPGDYGTFRPDALMYSVVTAWQTLSERIQ--GSFDGAFQP--VQL 220 
Momordin        ARFKYIEQQIQERA-----YRDEVPSLATISLENSWSGLSKQIQLAQGNNGIFRTPIVLV 216 
Saporin         ARFRYIQNLVTKNF-----PNKFDSDNKVIQFEVSWRKISTAIY-GDAKNGVF------- 224 
Dianthin        ARFRYIQNLVTKNF-----PNKFDSENKVIQFQVSWSKISTAIF-GDCKNGVF------- 225 
                ***:**:  : :             .    ..  :*  :*  *      :* *.    :  
 
 
Stenodactylin   GYASDPFYWDNVAQAITRLSLMLFACAKPPR 251 
Momordin        DNKGNRVQITNVTSKVVTSNIQLLLNTRNI- 246 
Saporin         -NKDYDFGFGKVRQVKDLQMGLLMYLGKPK- 253 
Dianthin        -NKDYDFGFGKVRQAKDLQMGLLKYLGRPKS 255 
                          :* .     .: *:         
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Table 3.2. Identity of t type 1 RIP with A-chain stenodactylin. 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Phylogenetic analysis 
To understand the relationship between stenodactylin and other type 2 RIPs (both toxic and 
non-toxic), phylogenetic trees were constructed based on the amino acid sequences of the A 
and the B chains of 11 families (Sambucaceae, Liliaceae, Cucurbitaceae, Fabaceae, 
Passifloraceae, Iridaceae, Laureceae, Euphorbiaceae, Viscaceae, Araliaceae and 
Olacaceae). In the evolutionary tree, all the 27 RIPs segregated into two major clusters for 
each chain. Interestingly, the A chain of stenodactylin is in the same cluster as the A chains of 
ricin and viscumin, while the B chain of stenodactylin is in the same side branch as the B 
chains of the non-toxic type 2 RIPs (Fig. 3.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Identity (%) 
(Stenodactylin) 
A chain 
Saporin 18.9 
Dianthin  18.1 
Momordin 24.0 
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Fig. 3.10. Phylogenetic tree of type 2 RIPs (A chain and B chain) belonging to different plant species. 
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BACKGROUND: RIPs and cell death mechanisms 
In the past, RIP cytotoxicity was commonly attributed to protein synthesis inhibition resulting 
from ribosomal damage, and this inhibition would be followed by necrosis. However, this 
view changed when Griffiths and co-workers observed morphological changes that are typical 
of apoptosis in cells in which ricin and abrin were concentrated after intramuscular injection 
into rats (Griffiths et al., 1987). Abrin- and ricin-treated cells exhibit condensation and 
breakdown of nuclear DNA into discrete fragments in bovine pulmonary endothelial cells 
(Hughes et al., 1996) and the human macrophage U937 cell line (Kochi and Collier, 1993). In 
addition to ricin and abrin, several other RIPs also induce apoptosis, such as viscumin 
(Bussing et al., 1996), saporin (Bergamaschi et al., 1996; Bolognesi et al., 1996), pokeweed 
anti-viral protein from seeds (PAP-S), momordin (Bolognesi et al., 1996) and trichosantin 
(Zhang et al., 2001; Li et al., 2007). 
Many studies have been conducted to understand the relationship between RIP N-glycosidase 
activity and the triggering of the apoptotic events. However, many questions have remained 
opened. 
Kochi and Collier proposed that apoptotic events become visible only when protein synthesis 
is inhibited by about 90% (Kochi and Collier, 1993). However, studies on rhabdomyosarcoma 
cells showed that α-sarcin induces DNA fragmentation, activation of caspase 3 and cleavage 
of PARP even at concentration slightly below its IC50 (the value representing the protein 
concentration required to kill 50% of the cells). In contrast, another inhibitor of protein 
synthesis, cycloheximide (CHX), did not induce any apoptotic effects even at concentrations 
that almost abolished protein synthesis (Olmo et al., 2001). The same authors demonstrated 
by indirect studies that the pan caspase inhibitor Z-Vad-fmk did not reduced α-sarcin-
inhibited protein synthesis activity, and they proposed that caspase activation was a 
downstream effect of the inhibition of protein synthesis. Moreover, they observed that even in 
the presence of the caspase inhibitor, a percentage of cells continued to die, suggesting the 
presence of both caspase-dependent and –independent cell death mechanisms. The same 
hypothesis that apoptosis and enzymatic activity on ribosomes are correlated was confirmed 
by results obtained when studying recombinant mistletoe lectin A chain (rMLA) mutants. The 
mutant form of mistletoe lectin showed greatly reduced activity in a cell-free system and this 
reduced activity was associated with very low cytotoxicity (Langer et al., 1999). 
Contrary to previous reports, many other studies have demonstrated that either the RIP 
activity was not sufficient to induce apoptosis or that the programmed cell death occurred 
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independent of translation inhibition. Studies with PAP mutants (Hur et al., 1995), ricin 
mutants (which are non toxic to yeast cells) (Li et al., 2007) and Shiga toxin (Di et al., 2011) 
demonstrated that the N-glycosidase activity of RIPs was not the only mechanism to induce 
apoptosis. In all these three cases, the ribosome-depurinating ability of the mutated RIPs was 
not altered, while their cytotoxic effects decreased. Particularly in ricin-treated cells, the 
hallmarks of apoptosis were not present. 
Other groups hypothesized that the translation inhibition was independent from apoptosis. 
These hypotheses were based on the results from temporal/dose studies or from mutant RIPs. 
In ricin-treated cells, morphological changes and the loss of mitochondrial membrane 
potential were observed before translation was completely inhibited (Soler-Rodrìguez et al., 
1993). Abrin mutant and saporin mutant that lacked translation inhibition activity induced 
apoptosis in Hela and U937 cells, respectively (Shih et al., 2001; Sikriwal et al., 2008). 
Moreover, low doses of RIPs, such as ricin, volkensin and riproximin, promote both the 
translation of unfolded protein response (UPR) genes and the activation of the apoptotic 
pathway (cleavage of PARP and caspase 7 activation). Therefore, the authors suggested that 
the apoptotic pathway is not induced by protein synthesis arrest in response to low 
concentrations of type 2 RIPs (Horrix et al., 2011). These reports confirm the idea that the 
inhibition of protein synthesis cannot be the only and the main cause of programmed cell 
death. 
By summarizing all of the studies performed over the last 20 years, three different hypotheses 
have been formulated concerning the rRNA N-glycosidase activity of RIPs, which seems to 
be (i) indispensable, (ii) necessary but not sufficient or (iii) unimportant for the induction of 
apoptosis (Das et al., 2012). 
In addition to the inhibition of translation, alternative mechanisms were proposed to explain 
how RIPs induce apoptosis, such as (a) the binding of the B chain to cell receptors, (b) the 
activation of UPR genes, (c) DNase activity, (d) interactions with anti-oxidant proteins and 
(e) the production of reactive oxygen species (Fig. 4.1). 
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                      Fig. 4.1. Some possible mechanism of apoptosis induced by RIPs (Das et al., 2012). 
The B chain is a lectin that binds cell surface receptors that contain sugar. Low concentration 
(nM) of Sambucus nigra agglutinins II (SNAII), which consist only of the carbohydrate-
binding B chains, induced caspase-dependent apoptosis in sensitive midgut CF-203 cells 
(Shahidi-Noghabi et al., 2010). In U937 cells, the B chain of ricin also produced DNA 
fragmentation and the morphological changes that are typical of apoptosis at a concentration 
that did not inhibit protein synthesis (Hasewaga et al., 2000).  
qRT-PCR was used to identify genes connected with the UPR, such as activating transcription 
factor 3 (ATF3), growth arrest and DNA damage inducible gene 153 (GADD153) and IL24; 
these genes are upregulated in a dose dependent manner after RIP treatment. Their 
overexpression suggests that the cells experience endoplasmic reticulum stress, with 
subsequent apoptosis (Horrix et al., 2011). 
An alternative apoptotic pathway induced by RIPs could be caused to their DNase activity. 
Different RIPs (e.g., ricin, cinnamomin, gelonin, saporin-6 and dianthin 30) introduce specific 
cleavages into supercoiled DNA (Ling et al., 1994; Roncuzzi and Gasperi-Campani, 1996; 
Brigotti et al., 2002). Moreover, studies on saporin mutant, show that for the complete 
cytotoxic activity of saporin both the RNA glycosidase the genomic DNA fragmentation 
activity are required (Bagga et al., 2003b). Using immunofluorescence assays and 
transmission electron microscopy, Bolognesi and co-workers found a nuclear localization of 
saporin-6. The presence of saporin in the nucleus suggests that one mechanism of cell death 
induced by the toxin could be DNA damage (Bolognesi et al., 2012). 
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In a study by Nicolas and co-workers, the cytotoxic effect of gelonin on Plasmodium 
falciparum was reported to be caused by the loss of parasite mitochondrial DNA and not the 
inhibition of protein synthesis (Nicolas et al., 1997). 
Another mechanism proposed to induce apoptosis was found in abrin-treated cells. Using a 
yeast two-hybrid system and an abrin mutant that lacks the N-glycosidase activity, the authors 
discovered an interaction between the toxin and the antioxidant protein-1 (AOP-1). AOP-1 is 
located in the mitochondria and protects the mithocondria from the action of reactive oxygen 
species. The abrin mutant interacted directly with AOP-1 to inactivate its antioxidant activity, 
with a consequent release of cytochrome c and activation of caspases (Shih et al., 2001). 
RIPs can also induce apoptosis by increasing the reactive oxygen species (ROS) and 
intracellular calcium levels. Trichosanthin causes ROS production in human choriocarcinoma 
cells (JAR cells) after it interacts with a membrane-bound receptor. In addition, the ROS 
levels increased in parallel with calcium level, suggesting that ROS production in 
trichosanthin-treated cells might be a consequence of calcium signaling (Zhang et al., 2001). 
In U937 cells, the toxin mistletoe lectin II (MLII) generated high levels of H2O2, which 
activated the intracellular stress signaling and JNK/SAPK pathways, concomitant with 
apoptosis. Treatment with an ROS scavenger was able to rescue the treated cells from 
apoptosis (Kim et al., 2003). The same cell line treated with a low dose of abrin showed an 
increase in ROS levels, followed by DNA damage (Bhaskar et al., 2008). 
The mitochondria play a major role in different stress-induced cell death pathways, and 
damage to the mitochondria induces the loss of  mitochondrial membrane potential, which is 
the point at which apoptosis is inevitable. Most of the mechanisms through which RIPs 
trigger the apoptotic pathway occur through the mitochondria. Bussing and co-workers found 
an increase in the expression of APO2.7 mitochondrial protein in ricin- and MLI-treated cells. 
APO2.7 is a 38 kDa mitochondrial membrane protein that is present in early apoptotic cells 
(Bussing et al., 1999). The involvement of the mitochondria was confirmed by the increased 
levels of Bak protein in hepatoma (BEL7404) cells after intoxication with ricin. Bak 
constitutively resides in the mitochondria and, after oligomerization, forms the mitochondrial 
permeability transition pore, which releases apoptosis factors (Hu et al., 2001). The 
mitochondrial pathway of apoptosis was also reported after intoxication with abrin. Treating 
Jurkat cells with abrin induced caspase 3 activation and subsequently DNA fragmentation, but 
its cytotoxic effect was independent by caspase 8 (Narayanan et al., 2004). The involvement 
of the intrinsic pathway was also observed in saporin-6-treated cells. After intoxication with 
this toxin, a time-dependent increase in caspase 9 activity and the release of cytochrome c in 
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the cytosolic fraction was observed. Because caspase 8 was not activated, no change in the 
level of Bid (a proapoptotic Bcl-2 member) was observed, and the Fas receptor was not 
overexpressed; these results indicated that the extrinsic pathway was not involved (Sikriwal et 
al., 2008).  
Recently, Bolognesi and co-workers found that ricin and saporin were able to induce the 
intrinsic and extrinsic pathways (i.e., after 4 h treatment by both RIPs) in a human Hodgkin’s 
lymphoma cell line (L540). However, ricin is more efficient than saporin at activating 
caspases 8 and 3/7, and its strong activation may due to the lectin property of the B chain. 
Moreover, they proposed a mechanism of cell death that is at least partially independent of 
both caspase activation and necrosis because a pan caspase inhibitor (Z-Vad) and a non-
apoptotic death inhibitor (necrostatin-1) could only partially rescued the cells from death 
(Polito et al., 2009a). 
The involvement of an alternative cell death pathway was also described by Bora and co-
workers. They found that treating a human B cell line (U266B1) with abrin increased the ROS 
levels and lysosomal membrane permeabilization, resulting in the release of cathepsin; in 
contrast, they did not observe apoptosis and caspase activation. The authors speculated that 
caspase-independent programmed necrosis was involved (Bora et al., 2010). Interestingly, the 
same toxin causes more than one death mechanism; Jurkat cells treated with abrin die via 
apoptosis in a caspase-dependent manner (Narayanan et al., 2005). 
Based on these data, RIPs clearly inhibit protein synthesis. Despite the different studies that 
have been conducted to elucidate the mechanism through which the RIPs trigger apoptosis, 
many unanswered question remain. Figure 4.2 shows the different signaling cascades and 
pathways that are induced by RIPs.  
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Fig. 4.2. Different types of mechanism of RIPs-induced apoptosis (Narayanan et al., 2005). 
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AIM OF THE WORK 
RIPs have been used alone or as the toxic component of immunotoxins that are used to 
experimentally treat many diseases, such as cancer, hematological disorders, and graft-versus-
host disease (GVHD), and as an antiviral agent in the therapy of AIDS; RIPs are used both for 
systemic and loco-regional treatments (Stirpe and Battelli, 2006). The best results have been 
reported in hematological neoplasias (Polito et al., 2011). For the clinical application of RIPs 
and other cytotoxic substances, it is preferable that the drug kills the target cells by apoptosis 
rather than necrosis because the latter causes an inflammatory response in the surrounding 
tissues. Knowledge of the cell death pathway(s) induced by RIPs could be useful for 
designing specific immunotherapies and for clarifying the mechanism of damage. 
Thus the purpose of the project was to understand the pathogenesis of cell intoxication caused 
by stenodactylin. Stenodactylin, which is extracted from the caudex of A. stenodactyla, was 
selected because little is known about its cytotoxic mechanisms even though it is the most 
toxic RIP. 
The experiments were performed using the neuroblastoma cell line NB100, which our 
laboratory has previously shown to be very sensitive to RIPs. Its high sensitivity allows us to 
conduct experiments with very low doses of toxin that are comparable to the doses that could 
be reached in vivo in immunotherapy. 
The cell death mechanisms induced by RIPs may depend on the cell type, the toxin, and the 
dose utilized.  
To better understand the cell death pathway(s) induced by stenodactylin in NB100 cells, two 
different concentrations of the toxin were used. The first series of experiments was performed 
using stenodactylin at its IC100 (value representing the protein concentration required to kill 
100% of the cells). The cell death mechanisms were evaluated using inhibitors of apoptosis 
and necroptosis and ROS scavengers.  
In the second series of experiments, stenodactylin cytotoxicity was evaluated by treating cells 
with a toxin concentration corresponding to the IC50. The role of rRNA N-glycosidase activity 
was evaluated by studying the temporal sequence of the key events that lead to cell damage 
induced by RIP. Caspase activation and protein and gene expression levels were quantified to 
understand the cell death mechanisms induced by stenodactylin. 
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RESULTS AND DISCUSSION 
4.1 Cell viability and protein synthesis inhibition assays  
Cell viability and protein synthesis inhibition assays were performed on a neuroblastoma cell 
line (NB100). The experiments were performed using stenodactylin (extracted from the 
caudex of A. stenodactyla), the most toxic type 2 RIP yet discovered and purified. The results 
were compared with two other RIPs: ricin (type 2 RIP, purified from the seeds of R. 
communis), and saporin (type 1 RIP, extracted from the seeds of S. officinalis). These RIPs 
are among the best known and most studied RIPs, and part of the death pathways are already 
known. 
The cytotoxicity of the RIPs was evaluated at 48 h using two indirect methods: the inhibition 
of protein synthesis and the viability. Protein synthesis was estimated from the inhibition of 
[3H] leucine incorporation, while the viability was assayed using a colorimetric method by 
MTS reduction. Both techniques were performed simultaneously to assess the correlation 
between translation impairment and cell viability (Fig. 4.3). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.3. Effect of stenodactylin (■), ricin (♦) and saporin (▲) on protein synthesis and viability in NB100 cells. 
Cells (2×104) were seeded in 24-wells plates in a total volume of 250 µl of complete medium containing various 
concentrations of RIPs. After 48 h of incubation and an additional 4 h with [4,5 3H]-leucine, the incorporated 
radioactivity was determined (A). Viability of NB100 cells (3×103 in 100 µl of complete medium) was evaluated 
after a 48 h exposure to the indicated concentrations of RIPs using a colorimetric assay based on MTS reduction 
(B). In both panels the results are the means of three independent experiments each performed in triplicate and 
are presented as the percentage of control values obtained from cultures grown in the absence of RIPs. 
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Dose-response curves, shown in Figure 4.3, demonstrated that protein synthesis and viability 
proceed in a parallel manner. As previously reported in other experimental models, the type 2 
RIPs exhibited a higher cytotoxicity compared with the type 1 RIP saporin (Polito et al., 
2009a). Protein synthesis and viability were completely inhibited by stenodactylin and ricin at 
10-12 and 10-11 M, respectively. The same cytotoxic effect was produced by saporin but at 
concentration of 10-8 M.  
The concentration of RIPs causing 50% and 100% inhibition of leucine incorporation (IC50, 
half maximal inhibitory concentration, and IC100, maximal inhibitory concentration) and of 
viability (EC50, effective concentration 50% and EC100, effective concentration 100%) was 
calculated by a linear regression analysis (Table 4.1). 
 
 STENODACTYLIN 
(M) 
RICIN 
(M) 
SAPORIN 
(M) 
EC50 2.5 x 10-14 6.5 x 10-13 1.8 x 10-11 
IC50 4.0 x 10-14 2.4 x10-13 2.0 x 10-11 
EC100 1.24 x 10-12 1.1 x 10-10 >10-8 
IC100 1.26 x 10-12 1.0 x 10-11 6.0 x 10-7 
Stenodactylin showed a stronger effect on both protein synthesis and viability, with IC50 and 
EC50 that were 1 and 3 log lower than ricin and saporin, respectively, and an IC100 that was 1 
log lower than ricin and 5 log lower than saporin. The EC100 of stenodactylin was 2 log lower 
than ricin and more than 4 log lower than saporin. 
The high toxicity of stenodactylin, at very low dose, could be advantageous for its use in loco-
regional treatment. By injecting a low amount of the RIP, which would be immediately taken 
up by cells without spreading to the surrounding tissue, a strong toxic effect could be reached, 
with a reduction of unwanted side effects. 
Moreover, these results demonstrated that the NB100 cell line was very sensitive to RIPs. In 
particular, saporin was more toxic in this cell line compared with the cell lines reported in the 
literature (Barbieri et al., 1993). 
.  
 
 
Table 4.1. IC50, IC100, EC50, EC100 of stenodactylin, ricin, saporin on NB100 cell line.  
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4.2 Evaluation of the cytotoxic effect of stenodactylin at the IC100 
concentration 
4.2.1 Assessment of apoptosis 
Apoptosis was first evaluated in cells treated with stenodactylin at a concentration of 10-12 M, 
and morphological changes were examined with phase contrast microscopy and fluorescence 
microscopy. A visual inspection of NB100 cells treated with stenodactylin (10-12 M) with 
phase contrast microscopy showed that the cells displayed the morphological features that are 
characteristic of apoptotic cells. 
After overnight exposure to the RIP (24 h), cell shrinkage, cell membrane blebbing, and 
cytoplasmic condensation became clearly evident. Apoptosis was monitored by fluorescence 
microscopy using DAPI nuclear staining and Annexin V-EGFP/PI staining. DAPI staining 
showed that the intoxication with the RIP led to nuclear blebs and nuclear condensation (Fig. 
4.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4. NB100 cell morphology without (a,c) and with stenodactylin (10-12 M) for 24 h (b,d). NB100 cells 
morphology assessed by phase contrast microscopy (a,b, 60× magnification) and fluorescence microscopy (c,d, 
60× magnification). 
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Annexin V is a sensitive probe for identifying apoptotic cells and binds with high affinity to 
phosphatidylserine (PS), which is flipped to the outer side of the plasma membrane during the 
early stage of apoptosis. Propidium iodide (PI) is a viability probe and is used to distinguish 
necrotic cells. Viable cells with intact membranes exclude PI, whereas the membranes of dead 
and damaged cells are permeable to PI. Cells that stain positive for Annexin V- EGFP and 
negative for PI are undergoing apoptosis (green). Cells that stain positive for both Annexin V-
EGFP and PI are in the end stage of apoptosis (green and red). Cells that stain negative for 
Annexin V-EGFP and positive for PI are necrotic (red).  
Double staining with Annexin V-EGFP/PI demonstrated that NB100 cells treated with 
stenodactylin (10-12 M) for 24 h showed the typical features of the late stage of apoptosis (Fig. 
4.5). 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5. Apoptosis as deteced with Annexin V-EGFP/PI in control cells (a-c) and stenodactylin (10-12 M)-treated 
cells (d-f). After 24 h, NB100 cells were stained with Annexin V-EGFP/PI and observed under a fluorescent 
microscope. (a, d) The membranes of apoptotic cells stained green with Annexin V-EGFP; (b, e) the nuclei of 
late stage of apoptosis or necrotic cells stained red with PI; (c, f) a dual-channel fluorescence view was creating 
by overlaying the images. 
To quantify the percentage of apoptotic cells after stenodactylin treatment, NB100 cells were 
stained with Annexin V-EGFP/PI and then analyzed by flow cytometry (Fig. 4.6). PI-positive 
cells are in the upper left quadrant, while cells in late apoptosis and early apoptosis are in the 
upper and lower right quadrants, respectively. After 24 h intoxication, most of the cells were 
in the late apoptotic stage (86.2%). Interestingly, a small percentage of cells (9.4%) were 
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positive only for PI, thus suggesting that these cells undergo a mechanism of cell death that is 
different from apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.6. Evaluation of apoptosis by Annexin V-EGFP/PI staining, followed by flow cyometry analysis. 
Representative plots of annexin V-EGFP/PI staining of NB100 cells cultured in the absence of presence of 
stenodactylin (10-12 M). 
A distinctive feature of programmed cell death is the disruption of active mitochondria. This 
mitochondrial disruption includes changes in the membrane potential and alterations to the 
mitochondria redox state. 
Alterations of the mitochondrial membrane potential (∆ψm) were detected by fluorescent 
microphotographs in cells that were exposed to stenodactylin (10-12 M) for 24 h and stained 
with JC-1 (Fig. 4.7). 
JC-1 is a lipophilic, cationic dye that can selectively enter the mitochondria and reversibly 
change color from green to red as the membrane potential increases. In healthy cells with high 
mitochondrial ∆ψm, JC-1 spontaneously forms J-aggregates with intense red fluorescence. In 
apoptotic or unhealthy cells with low ∆ψm, JC-1 remains in the monomeric form, which 
fluoresces green. 
In the mitochondria of control cells, JC-1 formed the characteristic J-aggregates, yielding red 
fluorescence, while in stenodactylin-treated cells, the JC-1 remained in the monomeric form 
producing a green fluorescence. 
These results confirm that the cells undergo apoptotic programmed cell death after RIP 
intoxication and that the mitochondria are involved. 
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Fig. 4.7. Mitochondrial transmembrane potential in NB100 cells treated with stenodactylin (10-12 M) for 24 h, 
stained with JC-1 and then analyzed with fluorescence microscopy. The untreated cells showed a strong red 
fluorescence, indicating intact mitochondrial membrane potential. Treated cells presented a green fluorescence 
that represents the monomeric form of JC-1, indicating dissipation of the ∆ψm. 
To confirm that the cells undergo caspase-dependent apoptosis, caspase 3/7 activation was 
measured in cells exposed to 10-12 M stenodactylin for 4, 6 and 8 h (Fig. 4.8). This experiment 
showed a time-dependent, strong activation of the effector caspases. After 8 h of intoxication, 
caspases 3/7 activation increased 770% compared with untreated cells. The high activation 
level of effector caspases confirmed that the cells underwent the caspase-dependent apoptosis, 
which was previously reported in cells treated with high doses of both type 1 and type 2 RIPs 
(Polito et al., 2009a). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.8. Caspase 3/7 activation in NB100 cells (3×103 cells) treated with stenodactylin (10-12 M). Caspases 
activity was expressed as the percentage of control values obtained from cultures grown in the absence of RIPs.  
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To determine the role of caspase-dependent programmed cell death, the pan-caspase inhibitor 
Z-Vad-fmk was used. Z-Vad-fmk (Z-Vad) irreversibly binds to the catalytic site of caspase 
proteases and inhibits apoptosis.  
NB100 cells were pretreated and maintained in 100 µM Z-Vad, and cell viability was 
determined with the MTS assay at different time points (24, 48, 72, 96 h). As shown in Figure 
4.9, Z-Vad signiﬁcantly inhibited the cytotoxicity of stenodactylin after 24 h from 
intoxication, yielding a viability of 98%±9%. The protective effect of the pan caspase 
inhibitor decreased over time, leading to 10% of viability at 96 h.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.9. Viability of NB100 cells (3×103 cells/well) treated with stenodactylin (10-12 M) alone (black circle) or 
in the presence (white circle) of 100µM Z-Vad. The pan-caspase inhibitor was added 3 h before the RIP was 
added, while stenodactylin was added for 2 h and the viability was observed after the indicating times. Viability 
was evaluated using a colorimetric assay based on MTS reduction. The results are the means of three 
independent experiments, with each performed in triplicate, and are presented as the percentage of control values 
obtained from cultures grown in the absence of RIPs. 
A loss of protection from cell death by the pan-caspase inhibitor starting at 48 h was not 
caused by its inactivation. Z-Vad was added every 24 h, and as reported in Figure 4.10, the 
effector caspases were effectively maintained at the basal level. 
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Fig. 4.10. Effect of stenodactylin (10-12 M) on the viability of (•) and caspase 3/7 activity in (columns) NB100 
cells. Cells were pretreated for 3 h with Z-Vad (100 µM) and then for 2 h with stenodactylin. The viability of 
NB100 cells (3×103 in 100 µl of complete medium) was evaluated at the indicate times with a colorimetric assay 
based on MTS reduction. Caspase 3/7 activity is expressed as the percentage of control values obtained from 
cultures grown in the absence of RIPs. The results are the means of three independent experiments, each 
performed in triplicate.  
Because Z-Vad rescued the cells from death 24 h from intoxication with stenodactylin, the 
apoptotic pathway appears to be the dominant and the fastest cell death mechanism induced 
by stenodactylin. However, the lack of total protection over time suggests that the toxin kills 
cells by activating more than one cell death mechanism, including probably necroptosis. 
Indeed, abrin can cause both caspase-dependent apoptosis and necroptosis (Bora et al., 2010). 
When programmed cell death is inhibited by Z-Vad, cells can still die through necroptosis 
(Declercq et al., 2009). Necroptosis is a programmed necrosis that occurs due to tumor 
necrosis factor receptor (TNF-R) activation. Like apoptosis, this programmed necrosis is 
highly regulated, and the cells show the same morphological features as cells undergoing 
necrosis (Gunther et al., 2012).  
Because necroptotic cells are similar to necrotic cells in terms of membrane changes, the 
Annexin V-EGFP/PI staining was used to confirm the necroptosis pathway in cells pretreated 
with Z-Vad (Fig. 4.11).  
Double staining was evaluated at 48 h, when the cell viability was < 50%. At this time, only 
red fluorescence was observed, indicating that cell membranes were damaged, and the typical 
PI staining of non-apoptotic dead cells was observed.   
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Fig. 4.11. Apoptosis as deteced with Annexin V-EGFP/PI in control cells (a-c) and cells pretreated for 3 h with 
Z-Vad (100µM) and then intoxicated for 2 h with stenodactylin, steno, (10-12 M) (d-f). After 48 h, NB100 cells 
were stained with Annexin V-EGFP/PI and observed under a fluorescent microscope. (a, d) The membranes of 
apoptotic cells stained green with Annexin V-EGFP; (b, e) the nuclei of late stage of apoptosis or necrotic cells 
stained red with PI; (c, f) a dual-channel fluorescence view was creating by overlaying the images  
4.2.2 Necroptosis  
To verify necroptosis in these cells, a set of experiments were performed using the inhibitor of 
necroptosis necrostatin-1.  
Necroptosis depends on the serine-threonine kinase receptor-interacting proteins 1 (R.I.P1) 
and 3 (R.I.P3), and other proteins. R.I.P1 plays a critical role in necroptosis, and its kinase 
activity is inhibited by necrostatin-1 (Christofferson and Yuan, 2010).  
In the presence of necrostatin, cell death was strongly but not completely inhibited at 24 h, 
with a viability of 70%±7%. Subsequently at 48, 72 and 96 h, cell viability decreased to 
approximately 25%. Therefore, necrostatin seems to be slightly more effective than Z-Vad in 
protecting cells from long-term intoxication (Fig. 4.12). 
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Fig. 4.12. Viability of NB100 cells (3×103 cells/well) treated with stenodactylin (10-12 M) alone (black circle) or 
in the presence (white circle) of necrostatin (Necro) 100µM. Necrostatin-1 was added 3 h before the RIP was 
added, while stenodactylin was added for 2 h and the viability was observed after the indicating times. Viability 
was evaluated using a colorimetric assay based on MTS reduction. The results are the means of three 
independent experiments, with each performed in triplicate, and are presented as the percentage of control values 
obtained from cultures grown in the absence of RIP. 
The 30% of cells that died by 24 h most likely died via the apoptotic pathway, as 
demonstrated by the activation of caspases 3/7. Moreover, the further decrease in cell viability 
was accomplished by a corresponding strong increase in the effector caspases’ activity (Fig. 
4.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.13. Effect of stenodactylin (10-12 M) on the viability of (•) and caspase 3/7 activity in (columns) NB100 
cells. Cells were pretreated for 3 h with necrostatin (100 µM) and then for 2h with stenodactylin. The viability of 
NB100 cells (3×103 in 100 µl of complete medium) was evaluated at the indicate times with a colorimetric assay 
based on MTS reduction. Caspase 3/7 activity is expressed as the percentage of control values obtained from 
cultures grown in the absence of RIP. The results are the means of three independent experiments, each 
performed in triplicate. Asterisks indicate level of significance in ANOVA, Dunnett’s test  ***p=0.001. 
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The hypothesis that the cells underwent apoptosis in the presence of necrostatin and 
stenodactylin was confirmed by Annexin V-EGFP/PI staining. The apoptotic pathway was 
evaluated after 48 h from intoxication, when the viability was < 60%. In these conditions, 
cells showed characteristics of both early and late apoptosis (Fig. 4.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.14. Apoptosis as deteced with Annexin V-EGFP/PI in control cells (a-c) and cells pretreated for 3 h with 
100µM necrostatin (Necro) and then intoxicated for 2 h with stenodactylin, steno, (10-12 M) (d-f). After 48 h, 
NB100 cells were stained with Annexin V-EGFP/PI and observed under a fluorescent microscope. (a, d) The 
membranes of apoptotic cells stained green with Annexin V-EGFP; (b, e) the nuclei of late stare of apoptosis or 
necrotic cells stained red with PI; (c, f) a dual-channel fluorescence view was creating by overlaying the images  
Apoptotic morphological changes were examined by phase contrast microscopy. After 24 h, 
cells treated with one of the inhibitors and stenodactylin resemble the untreated cells, while 
morphological alterations were present after longer times of exposition. However, different 
morphological features were visible in cells treated with the RIP alone or in combination with 
Z-Vad or necrostatin-1, suggesting that more than one cell death mechanism was triggered 
(Fig. 4.15).  
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Fig. 4.15. NB100 cell morphology of cells treated with stenodactylin (10-12 M) in the absence (steno) or in the 
presence of the pan-caspase inhibitor Z-Vad, and in the presence of necrostatin 1 (necro). The cells (2× 104/ 500 
µl of complete RPMI) were incubated with RIP for the indicated time and analyzed by phase contrast 
microscopy. 
4.2.3 Evaluation of oxidative stress  
Previous studies showed a significant increase in reactive oxygen species (ROS) production in 
cells treated with RIP (e.g., HeLa cells intoxicated with ricin). The authors suggest that the 
apoptotic cells death induced by the RIP is correlated with the production of reactive oxygen 
species (Rao et al., 2005). 
The involvement of ROS after treatment with stenodactylin was measured both directly and 
indirectly through fluorescence microscopy and a viability evaluation after the addition of 
scavenger molecules, respectively. 
The presence of total ROS and superoxide was evaluated in NB100 cells that were treated 
with stenodactylin (10-12 M) for 8 h.  
The total ROS detection dye reacts directly with a wide range of reactive species, such as 
hydrogen peroxide, peroxynitrite and hydroxyl radicals, to yield a green fluorescent product. 
The superoxide detection dye is a cell-permeable probe that reacts specifically with 
superoxide, generating a red fluorescent product. 
The results showed both red and green coloration, indicating an involvement of superoxide 
and others reactive species (Fig. 4.16). 
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Fig. 4.16. Fluorescent microscopy profiling of reactive oxygen species formation in NB100 cells that were 
untreated (a-c) and treated with stenodactylin (10-12 M) for 8 h (d-f) and loaded with ROS/superoxide detection 
reagents. Superoxide production was detected in the orange channel (a, d), while general oxidative stress levels 
were monitored in the green channel (b, e), dual-channel fluorescence view was created by overlaying the 
images (c, f). 
To quantify the superoxide production after 8 h of intoxication with stenodactylin, NB100 
cells were stained with superoxide detection kit and analyzed by flow cytometry.  
Figure 4.17 shows that in treated sample, 11.3% of cells were positive to superoxide, while in 
the untreated sample the superoxide positive cells were 1.2%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.17. NB100 cells that were untreated or treated with stenodactylin (10-12 M) for 8 h and then stained with a 
superoxide detection kit and analyzed with flow cytometry. 
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Together, the results obtained by fluorescence and flow cytometry suggest that after a short 
intoxication with stenodactylin, superoxide production is increased. This result supports the 
idea that the RIP lead to a very early formation of radical species and that ROS are important 
mediators of stenodactylin-induced cell death. 
To demonstrate the possible formation of ROS induced by stenodactylin, two ROS 
scavengers, superoxide dismutase (SOD) and catalase (Cat), were used in time-course 
experiments. SODs catalyze the dismutation of superoxide into oxygen and hydrogen 
peroxide. There are three different types of SODs, depending on the metal cofactor: 
cytoplasmatic Cu2+/Zn2+ SOD , mitochondrial Mn2+ SOD and extracellular Cu2+ /Zn2+ SOD. 
Catalase catalyzes the decomposition of hydrogen peroxide to water and oxygen, and it is 
localized in the peroxisomes.  
The viability of NB100 cells pretreated with the scavenger and then with stenodactylin (10-12 
M) was measured at different timepoints (24, 48, 72, 96 h). The H2O2 scavenger catalase 
completely suppressed stenodactylin-induced cell death after 24 h from intoxication. This 
protective effect decreased over time, reaching a plateau of 50% 48 h from intoxication (Fig. 
4.18A). No protective effect was detected when the cells were pretreated with SOD at any 
evaluated time point. The same results were obtained using either the extracellular Cu2+/Zn2+ 
SOD or the mitochondrial Mn2+ SOD (Fig. 4.18B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.18. Viability of NB100 cells (3×103 cells/well) treated with stenodactylin (10-12 M) alone (black circle) or 
in the presence (white circle) of Cat (10 U/ml) (A) or Cu2+/Zn2+SOD (100 U/ml) (B). The scavengers were added 
3 h before RIP was added, while stenodactylin was added for 2 h and the viability was observed after the 
indicating times. Viability was evaluated using a colorimetric assay based on MTS reduction. The results are the 
means of three independent experiments, with each performed in triplicate, and  are presented as the percentage 
of control values obtained from cultures grown in the absence of RIP. 
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These data suggest that stenodactylin induces the production of superoxide but that it is 
immediately converted to hydrogen peroxide, and this conversion appear to be very important 
because SOD was unable to protect cell from RIP-induced cell death. Moreover, hydrogen 
peroxide appears to have an important role in the pathogenic mechanism because catalase was 
able to rescue the cells from death.    
There are controversial reports about the role of caspase 3 in the formation of ROS. In some 
cases, caspase 3 assumes an important function in the production of reactive species, while 
other reports indicate that the hydrogen peroxide activates caspase-dependent cell death 
(Zhang et al., 2001). 
Earlier, stenodactylin was shown to activate caspases 3/7 to >750% of control activity levels 
after 8 h from intoxication (Fig. 4.8). To determine whether the effector caspases are activated 
by ROS or by other mechanisms that activate the effector caspases, the activation of effector 
caspases was evaluated in the presence of catalase. Time-course experiments showed that 
caspases started to be significantly activated starting after 48 h of incubation with the RIP, 
reaching 300% of control activity after 96 h from treatment, at which point cell viability was 
50% in the presence of catalase (Fig. 4.19). The maximal caspases 3/7 activation obtained in 
the presence of catalase was lower than stenodactylin-treated cells, indicating that a 
percentage of caspase 3/7 is activated through other RIP-induced mechanisms (e.g., DNA 
damage, intrinsic-extrinsic pathway). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.19. Effect of stenodactylin (10-12 M) on the viability of (•) and caspase 3/7 activity in (columns) NB100 
cells. Cells were pretreated for 3 h with Cat (10 U/ml) and then for 2 h with stenodactylin. The viability of 
NB100 cells (3×103 in 100 µl of complete medium) was evaluated at the indicate times with a colorimetric assay 
based on MTS reduction. Caspase 3/7 activity is expressed as the percentage of control values obtained from 
cultures grown in the absence of RIPs. The results are means of three independent experiments each performed 
in triplicate. 
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To confirm that stenodactylin actives the caspases 3/7 via ROS and other mechanisms, cell 
viability was evaluated after co-treatment with Z-Vad and catalase. The time-course 
experiments showed that the combination of Z-Vad and the scavenger led to complete 
protection from cell death over time, even at 96 h (Fig. 4.20). Previous studies demonstrated 
100% viability in the presence of Z-Vad (Fig 4.9) or catalase (Fig. 4.18) but only for 24 h. 
These data suggest that the caspase-dependent pathway and the ROS production are the main 
cell death mechanisms involved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.20. Viability of NB100 cells (3×103 cells/well) treated with stenodactylin (10-12 M) alone (black circle) or 
in the presence (white circle) of Z-Vad (100µM) + Cat (10 U/ml).The scavengers were added 3 h before the RIP 
was added, while stenodactylin was added for 2 h and the viability was observed after the indicating times. 
Viability was evaluated using a colorimetric assay based on MTS reduction. The results are the means of three 
independent experiments, which each performed in triplicate, and are presented as the percentage of control 
values obtained from cultures grown in the absence of RIP. 
To confirm that the apoptotic pathway is activated in cells pretreated with catalase, the cells 
were stained with Annexin V EGFP/PI. The cells showed the typical pattern of early and late 
apoptotic cells (Fig. 4.21). 
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Fig. 4.21. Apoptosis as deteced with AnnexinV-EGFP/PI in control cells (a-c) and cells pretreated for 3 h with 
Cat (10U/ml) and then intoxicated for 2 h with stenodactylin, steno, (10-12 M) (d-f). After 48 h, NB100 cells were 
stained with AnnexinV-EGFP/PI and observed under a fluorescent microscope. (a, d) The membranes of 
apoptotic cells stained green with AnnexinV-EGFP; (b, e) the nuclei of late stage of apoptosis or necrotic cells 
stained red with PI; (c, f) a dual-channel fluorescence view was creating by overlaying the images  
To confirm that the enzymatic activity of catalase was important for its protective effect, cells 
were pretreated using heat-inactivated catalase (Cat HI). In addition, the cells were pretreated 
with another scavenger, sodium pyruvate (NaPyruvate or NaPyr). NaPyruvate is a strong 
hydrogen peroxide scavenger that reacts stoichiometrically with H2O2 to protect cells from 
peroxide toxicity. 
Viability was measured after 24 h from the intoxication. Cells that were pretreated with Cat 
HI were completely dead, similar to cells treated with stenodactylin, while pretreatment with 
NaPyruvate decreased cell death, but less efficiently than catalase (80% vs. 100% viability 
with NaPyr and Cat, respectively). These results confirmed that stenodactylin induces the 
production of hydrogen peroxide and that the total protective effect of Cat occurs through its 
enzymatic activity (Fig. 4.22).  
 
 
 
 
 
C
tr
l 
a b c 
d e f 
Annexina V-EGFP PI Merge 
St
en
o
+
 
C
a
t 
Cell death mechanisms induced by Stenodactylin 
 77 
 
 
 
 
 
 
Fig. 4.22. Viability of NB100 cells treated with stenodactylin alone or in the presence of Cat (10 U/ml), heat 
inactivated catalase, Cat HI (10 U/ml) or NaPyruvate, NAPyr (1mM). The scavengers were added 3 h before RIP 
was added, while stenodactylin was added for 2 h and the viability was observed after 24 h from the intoxication 
with the RIP. The results are the means of three independent experiments, each performed in triplicate, and are 
presented as the percentage of control values obtained from cultures grown in the absence of the RIP. 
To ensure that the result obtained with catalase was not due to an experimental artifact, 
inhibition of protein synthesis in a cell-free system, native PAGE and fluorescence analysis of 
stenodactylin cell binding were performed in the presence of catalase, stenodactylin or both. 
Catalase and stenodactylin together inhibited protein synthesis in vitro by 35%, comparable to 
the inhibition measured with the RIP alone (45%). This result indicates that the scavenger 
does not modify the enzymatic activity of stenodactylin (data not shown). 
The native PAGE analysis showed only two bands when the RIP and the scavenger were 
incubated together. These bands correspond to catalase and stenodactylin. The results indicate 
that the scavenger did not block the RIP; indeed, no band was higher than the one 
corresponding to catalase, indicating that the scavenger did not produce steric hindrance. 
Moreover, no band was lower than the one corresponding to the RIP, indicating that the 
disulfide bridge was not reduced (Fig. 4.23).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.23. Native PAGE under non-reducing conditions of the combination of catalase and stenodactylin (lane 1), 
catalase alone (lane 2), and stenodactylin alone (lane 3). 
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Catalase did not compete for the same binding site receptor of stenodactylin. Indeed, in cells 
treated with stenodactylin and subsequently with an anti-stenodactylin antibody, the RIP (red 
dots) was observed inside the cells, both in the presence and in the absence of the scavenger 
(Fig. 4.24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.24. Fluorescence microscopy of NB100 cells loaded with an anti-stenodactylin antibody after incubation 
with stenodactylin in the presence or absence of catalase. White arrows indicate stenodactylin red dots. 
4.2.4 Assessment of autophagy 
Autophagy is a cellular degradation process that involves the lysosomal breakdown of 
cytoplasmic components. It is maintained at basal level in most cells and contributes to the 
routine turnover of cytoplasmic components. After stress or pathological stimuli, its activation 
is increased. Reactive oxygen species are implicated in the activation of this cellular 
mechanism. There are two controversial hypotheses concerning the induction of autophagy by 
ROS. Autophagy could be a cell-survival mechanism and cause a decrease in ROS levels by 
disrupting ROS-producing compartments. Alternatively, autophagy could act as a cell death 
mechanism when high levels of ROS are present. In these conditions, autophagy self-digests 
components of the cell and leads to cell death (Huang et al., 2011).  
The microtubule-associated protein light chain 3 (LC3) is a marker of autophagy and is a 
major constituent of autophagosome, a double membrane structure that sequesters the target 
organelle/protein and then fuses with endo/lysosomes. During autophagy, LC3 is cleaved to 
generate the cytosolic form LC3I, which is subsequently conjugated to 
phosphatidylethanolamine to form LC3II, which is in turn recruited to autophagosomal 
membranes (Kabeya et al., 2000; Tanida et al., 2008).  
To verify the activation of autophagy, a preliminary experiment was performed in cells 
treated with stenodactylin (10-12 M) for 8 h. The experiment was conducted at 8 h because, as 
reported previously, the formation of ROS was already detected at this time. Western blot 
Stenodactylin Ctrl Stenodactylin + Cat 
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analysis showed the presence of the two bands of LC3: LC3I (18 kDa) and LC3II (16 kDa), 
thus confirming that autophagy is triggered (Fig. 4.25A). Densitometric analysis of band 
intensity showed that stenodactylin induced an increase of LC3II levels compared with 
untreated cells, while the cytosolic form of LC3 decreased (Fig. 4.25B). The data are 
significantly different with a confidence range of 90%. 
 
 
 
 
 
  
 
 
 
 
 
 
 
Fig. 4.25. Expression of LC3 by western blot analysis in NB100 cells treated with stenodactylin (10-12 M) for 8 
h. The band at 18 kDa corresponds to LC3I, while the band at 16 kDa correspond to LC3 II. The same blot was 
hybridized with anti-β-actin as loading control (A). Densitometric analysis of LC3 expression by western blot 
analysis in cells treated with stenodactylin (10-12 M). The data were normalized to the respective loading control 
(β-actin). The columns represent the bands density calculated by Image J software. The values are the means ± 
SD of two independent experiments. Data were analyzed by ANOVA, followed by a comparison with Dunnett’s 
test, using a 90% confidence interval. 
Summarizing all the results obtained in NB100 cells intoxicated with the IC100 of 
stenodactylin (10-12 M), we speculate that the RIP can activate the effector caspases (perhaps 
through the DNA damage and/or by intrinsic and extrinsic pathways) and causes the 
formation of the superoxide radical. The latter is immediately converted to hydrogen 
peroxide, which causes or contributes to caspase-dependent apoptosis. H2O2 can also activate 
other cell death mechanisms, such as necroptosis and/or autophagy (Fig. 4.26A). 
Pretreatment with Z-Vad protects the cells from apoptosis for a limited time spare, after 
which the cells start to die, most likely of catalase consumption and accumulation of H2O2, 
which could cause necroptosis and/or autophagy. Several reports have indicated that 
autophagy can be caused by necroptosis and Z-Vad (Degterev et al., 2005; Bell et al., 2008; 
Bonapace et al., 2010). Indeed, Z-Vad can cause autophagic degradation of catalase, thus 
inducing an increase in ROS accumulation. (Yu et al., 2006) (Fig. 4.26B). 
With catalase, hydrogen peroxide is converted to water and oxygen. Over time, the cells start 
to die, perhaps through other mechanisms that activate the effector caspases (Fig. 4.26C).  
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Co-treatment with catalase and Z-Vad rescues the cells from death even after 96 h from the 
treatment. The hydrogen peroxide formed after treatment with stenodactylin is converted to 
water and O2 by catalase, while Z-Vad protects the cells from caspase-dependent cell death 
(Fig. 4.26D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.26. A probably scheme for cell death  mechanisms of  induced by stenodactylin:  alone(A), with Z-Vad (B), 
with the scavenger catalase (CAT) (C), and in the presence of catalase and Z-Vad (D).  
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4.3 The cytotoxic effect of RIPs at IC50 concentration 
4.3.1 Inhibition of protein synthesis and activation of caspases 3/7  
Many open questions remain about the importance of inhibiting protein synthesis during the 
induction of apoptosis. To understand the mechanism underlying RIP-induced cell death, in 
particularly the role of rRNA N-glycosidase activity, the activation of effector caspases 3/7 
and the inhibition of protein synthesis were evaluated in parallel experiments. In this set of 
experiments, stenodactylin was compared with another type 2 RIP (ricin) and a type 1 RIP 
(saporin) to evaluate possible differences in the dynamics of intoxication between mono- and 
bichain RIPs. All time-course experiments were performed using the IC50 calculated above: 
10-14 M, 10-13 M and 10-11 M for stenodactylin, ricin, and saporin, respectively. The IC50 were 
chosen for the following reasons: (i) high doses could be too strong and cause fast cell death, 
which would prevent studying the temporal events induced by RIPs and (ii) high RIP 
concentrations could be more favorable to one cell death mechanism than another. In these 
experiments with IC50, type 2 RIPs induced a strong activation of caspases 3/7, which was 
significant after only 4 h of incubation, followed by an exponential increase over time (Fig. 
4.27). Activity was increased approximately 1500 and 1200% of control activity levels with 
stenodactylin and ricin, respectively. In contrast, protein synthesis became significant 
inhibited only after 24 h of incubation with both RIPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.27. Effect of the type 2 RIPs, stenodactylin (10-14 M) and ricin (10-13 M), on protein synthesis (♦) and 
caspase 3/7 activity (columns) in NB100 cells. Caspases 3/7 activity is expressed as the percentage of control 
values obtained from cultures grown in the absence of RIPs. The results are the means of three independent 
experiments, each performed in triplicate. Asterisks indicate the level of significance as determined by ANOVA, 
Dunnett’s test *** p=0.001. 
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In cells treated with saporin, the effector caspases started being significantly activated only 
after 16 h of incubation, reaching 600% at 24 h. As observed with type 2 RIPs, the inhibition 
of protein synthesis became significant after 24 h of intoxication (Fig. 4.28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.28. Effect of the type 1 RIP saporin (10-11 M) on protein synthesis (♦) and caspase 3/7 activation 
(columns) in NB100 cells. Caspases 3/7 activity is expressed as the percentage of control values obtained from 
cultures grown in the absence of RIP. The results are the means of three independent experiments each 
performed in triplicate. Asterisks indicate level of significance as determined by ANOVA, Dunnett’s test  *** 
p=0.001. 
These data demonstrate that in cells treated with a relatively low dose of RIP, the first effect 
produced is the activation of caspases 3/7, even before the inhibition of protein synthesis is 
detectable. Indeed, the effector caspases activation increased starting at 4 h for stenodactylin 
and ricin and from 16 h for saporin, while the protein synthesis was not inhibited until 24 h 
for all the three RIPs. The delayed activation of caspases 3/7 in saporin-treated cells was 
caused by its less efficient entry into cells due to the lack of the B chain. 
These results show that caspase activation occurs independently from the inhibition of protein 
synthesis. This finding suggests that the different mechanisms of cell death induced by RIPs 
are distinct from rRNA deadenylation. Moreover, the toxicity of the RIPs was primarily due 
to caspases activation and not to inhibition of protein synthesis. 
Activation of caspases 3/7 is the most common hallmark of apoptosis. To confirm this cell 
death pathway, Annexin V-EGFP/PI staining was performed on NB100 cells treated with 
stenodactylin 10-14 M, ricin 10-13 M and saporin 10-11 M, 48 h of intoxication (Fig. 4.29). 
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Fig. 4.29. Apoptosis as detected with Annexin V-EGFP/PI in (a-c) stenodacrtylin-, (d-f) ricin-, (g-i) saporin-
treated cells. After 48 h NB100 cells (2×104/500µl complete RPMI) intoxicated with RIPs were stained with 
Annexin V-EGFP/PI and observed under fluorescence microscope. (a, d, g) The membranes of apoptotic cells 
stained green with Annexin V-EGFP; (b, e, h) the nuclei of apoptotic or dead cells stained red stained with PI; (c, 
f, i) a dual-channel fluorescence view was creating by overlaying the images.  
All three RIPs caused apoptosis; indeed, after 48 h of intoxication with RIPs, the majority of 
cells were positive for Annexin V-EGFP and PI, thus indicating that the cells were in the end 
stage of apoptosis. 
4.3.2 Evaluation of apoptotic cell death  
As earlier observed, intoxication with stenodactylin 10-14 M led to activation of caspases 3/7 
in a time- dependent manner.  
The early activation of effector caspases in cells treated with stenodactylin (10-14 M) was 
confirmed by the change of poly(ADP ribose) polymerase (PARP).  
PARP is one of the first identified cellular substrates that is cleaved during apoptosis by 
caspase 3, and it is important for DNA repair. Whole cell extracts were analyzed for PARP by 
immunoblotting. In stenodactylin-treated cells, intact 116-kDa PARP was degraded to  the 85-
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kDa form at 8 h when caspase-3 activation was highly detectable (800%) (Fig. 4.30A). 
Moreover, densitometric analysis of band intensity showed increases expression of PARP in 
treated cells compared with untreated cells, which may have been caused by a stress response 
to the RIP intoxication (Fig. 4.30B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.30. Expression of PARP analyzed, by western analysis in NB100 cells treated with stenodactylin (10-14 M) 
for 8, 16, 24 h. The band of 113 kDa corresponds to PARP, while the band of 86 kDa correspond to PARP 
fragment. The same blot was hybridized with anti-β-actin as loading control (A). Densitometric analysis of 
PARP expression by western blot analysis in cells treated with stenodactylin (10-14 M). The data were 
normalized to the respective loading control (β-actin). The columns represent the bands density calculated by 
Image J software. The values are the means ± SD of two independent experiments. Asterisks indicate level of 
significance as determined ANOVA, Dunnett’s test *** p=0.001 (B). 
4.3.2.1 Involvement of the intrinsic and extrinsic apoptotic cell death pathways 
Cell death through apoptosis occurs through two primary pathways, an extrinsic pathway 
involving death receptors, and an intrinsic pathway through the mitochondria. The receptor-
mediated pathway is triggered by an external stimulus and activates initiator caspases such as 
caspases 8 and 2. The mitochondrial pathway is normally triggered by internal stresses that 
activate caspase 9. The caspases activate effector caspases 3/7.  
To study the involvement of the intrinsic and extrinsic pathways in stenodactylin-induced 
apoptosis, the activation of caspases 8, 2 and 9 was evaluated in time-course experiments 
(Fig. 4.31).  
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Fig. 4.31. Caspases activation in NB100 cells (4×103 cells) exposed to stenodactylin (10-14 M). The enzymatic 
activity of caspases were measured by luminometric assay. Caspases activity is expressed as the percentage of 
control values obtained from cultures grown in the absence of RIP. Asterisks indicate level of significance as 
determined by ANOVA, Dunnett’s test *** p=0.001. 
The results showed that all the caspases had a similar trend but a variable activation time. 
Caspase 8 and 2 were significantly activated after 8 h of intoxication, while the intrinsic 
caspase 9 was significantly activated after 16 h. Caspase 8 can also induce the intrinsic 
pathway. Indeed, caspase 8 causes the cleavage of Bid protein to a truncated form (tBid), 
which translocates to the mitochondria and subsequently activates caspase 9 (Li et al., 1998). 
From the results obtained, we assume that (i) the caspase 9 is not activated directly by RIP but 
most likely by caspase 8 because caspase 9 activation was detectable 8 h after caspase 8 
and/or (ii) the activation of caspase 9 requires more time.   
Moreover, the highest levels of caspase activation were observed for caspase 8 (400 % at 24 
h). The earliest activation of the extrinsic pathway was reported for lymphoma cells treated 
with ricin and saporin (Polito et al., 2009a).  
The role of the intrinsic apoptosis pathway was evaluated using the caspase 8 inhibitor Z-
IETD-fmk. The activation of caspases 3/7 in the presence of the caspase 8 inhibitor was tested 
16 h after the beginning of the treatment with RIP, when the effector caspases were highly 
activated. In the presence of the Z-IETD, the caspase 8 activity was completely inhibited, 
while the activation of caspases 3/7 were only 28% lower than in the absence of the inhibitor 
(Fig. 4.32).  
These results suggest that although the caspase 8 was the most active caspase, other caspases 
activated the effector caspases. Thus, at this time, the activated caspase 2 and caspase 9 may 
play an important role in the activation of effector caspases. 
 
Time (h) 
Caspase 2  Caspase 8  
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
Caspase 9  
C
a
sp
a
se
 
a
ct
iv
a
tio
n
 
(%
ct
rl
) 
Cell death mechanisms induced by Stenodactylin 
 86 
 
 
 
 
 
 
 
 
Fig. 4.32. Effect of caspase-8-inhibitor Z-IETD (25µM) on caspase 8 and 3/7. Inhibitor was added to NB100 cell 
3 h before the RIPs. The caspases activation were valuated after 16 h of exposure to stenodactylin (10-14 M), ricin 
(10-13 M). 
As mentioned above, in cells treated with stenodactylin (10-14 M) caspase 9 began to be 
significantly activated after 16 h of incubation, although with a very low value when 
compared with caspase 8 activity. To confirm that the intrinsic pathway was partially 
involved in the apoptotic cell death pathway, the dissipation of mitochondrial membrane 
(∆ψm) was evaluated. The cells were treated with stenodactylin (10-14 M) for 16 h and the 
∆Ψm was examined by evaluating the changes in fluorescence intensity of cells stained with 
JC-1. In healthy cells with high ∆ψm, JC-1 forms J-aggregates with intense red fluorescence. 
In apoptotic cells with low ∆ψm, JC-1 remains in the monomeric form (green fluorescence). 
As shown in Figure 4.33 the treatment did not affect JC-1 fluorescence; indeed, there were 
not differences between untreated and treated cells, indicating a lack of mitochondrial 
involvement. 
 
 
 
 
 
 
 
 
Fig. 4.33. Mitochondrial transmembrane potential in NB100 cells (2×104/500µl complete RPMI) treated with 
stenodactylin (10-14 M) for 16 h, stained with JC-1 and then analyzed with fluorescence microscopy. The 
untreated and treated cells showed a strong red fluorescence, indicating intact mitochondrial membrane potential.  
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To further evaluate the intrinsic apoptotic signaling pathway in cell treated with stenodactylin, 
the expression of two proapoptotic member of Bcl-2 protein family, Bax and Bad, was 
evaluated. 
Bad is involved in initiating apoptosis. It can form a heterodimers with anti-apoptotic proteins 
and prevent them from inhibiting apoptosis. Bax increases the opening of the mitochondrial 
voltage-dependent anion channel (VDAC), which leads to the loss of the mitochondrial 
membrane potential and the release of cytochrome c. 
Total cellular proteins from NB100 cells treated with 10-14 M stenodactylin were analyzed by 
western blot using anti-Bax and anti-Bad primary antibodies, at different time points. 
Western blot and quantitative densitometric analysis showed only a slight decrease of Bad 
expression at 4 h, while the expression of Bax protein was slightly lower when compared with 
untreated cells at all time points. However, the two markers involved in intrinsic apoptosis did 
not show any significant differences when compared with the controls (Fig. 4.34).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.34 Total cellular proteins from NB100 cells that were treated with stenodactylin (10-14 M) were analyzed 
by western blot using anti-Bad and anti-Bax antibodies, followed by reprobing with a β-actin antibody. The Bad 
(A) and Bax (B) protein levels remained unchanged. The quantitative densitometric analyses for the Bad (C) and 
Bax (D) proteins normalized to β-actin. Values are presented as the mean ± SD of two independent experiments. 
Subsequently using the quantitative real-time PCR, the mRNA expression levels of the Bad 
and Bax genes were analyzed. All values were adjusted for the expression of glyceraldehyde-
3-phosphate dehydrogenase GAPDH, which was determined to be the most stable 
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housekeeping gene in this cell line. After stenodactylin treatment, a small increase of Bad was 
observed, but in both genes, no significant differences were observed compared with control 
cells (Fig. 4.35).  
 
 
 
 
 
 
 
 
 
Fig. 4.35. Mean fold expression of mRNA of pro-apoptotic genes after treatment of stenodactylin (10-14 M) in 
NB100 cells. A EvaGreen (SBYR) real-time PCR was used to detect mRNA of Bad (A) and Bax (B). Analysis 
of mRNA levels was evaluated by the 2−∆∆Ct method. Values were normalized to GADPH mRNA expression 
and the data presented are the mean of three experiments. 
The involvement of the extrinsic cell death pathway was investigated by evaluating the 
expression of Receptor Interacting Protein-1 (R.I.P.1) by western blot analysis.  
R.I.P.1 contains a death domain that may be recruited to the TNFR1 and Fas (CD95) receptor 
signal complexes following ligand binding. It is important for NF-kB activation and the 
triggering of apoptosis or necroptosis. Upon stimulation, two different complexes can be 
formed within the cell: complex I and complex II (A and B). In complex I, R.I.P.1 is 
polyubiquitinated, which activates NF-kB pathway and leads to the expression of prosurvival 
genes. When R.I.P.1 is deubiquitinated by A20 and Cyld, it translocates to complex II. There 
are two complexes II: TRADD- dependent complex IIA and R.I.P.1 kinase-dependent 
complex IIB. Complex IIA is formed by TRADD, FADD and activated caspase 8, which 
causes the cleavage of R.I.P.1 and R.I.P.3, thereby blocking necroptosis and inducing 
apoptosis. Complex IIB acts independently of TRADD through a R.I.P.1-FADD scaffold to 
activate caspase 8 in a R.I.P.1 kinase-dependent manner, which induces the apoptosis 
pathway. 
When caspase 8 is inactivated (e.g., by Z-Vad), R.I.P.1 and R.I.P.3 assemble a complex that 
contains FADD and caspase 8 (and eventually TRADD), and the interdependent 
phosphorylation of R.I.P.1 and R.I.P.3 activates necroptotic signaling (Declercq et al., 2009; 
Gunther et al., 2012).  
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Figure 4.36 demonstrates an increase in R.I.P.1 expression after intoxication with 10-14 M 
stenodactylin for only 8 h, and this increase became significant at 24 h.  
Because caspase 8 is activated and R.I.P.1 is expressed after 24 h of intoxication with 
stenodactylin, the complex IIA may have formed within the cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.36. Total cellular proteins from NB100 cells treated with stenodactylin (10-14 M) were analyzed by western 
blot using anti-R.I.P.1 antibody, the same blot was hybridized with anti- β-actin as loading control. A long-time 
exposure an increase of R.I.P.1 protein level was observed (A). Densitometric analyses of R.I.P.1 expression by 
western blot analysis in cells treated with stenodactylin (10-14 M). The data were normalized to the respective 
loading control (β-actin). The columns represent the bands density calculated by Image J software. The values 
are the mean ± SD of two independent experiments (B). Asterisks indicate level of significance by ANOVA, 
Dunnett’s test  ** p=0.01. 
Altogether, apoptosis appears to be the main mechanism of cell death induced by RIPs 
because protein synthesis is inhibited after programmed cell death begins. Moreover, our data 
suggest that the extrinsic apoptotic pathway is the most relevant death mechanism induced by 
stenodactylin intoxication.  
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 on NB100 cells  
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BACKGROUND: Ribosome inactivating proteins from Sambucus 
The Sambucus genus is composed of approximately 20 species. Numerous type 1 and type 2 
RIPs and homolectins have been found in Sambucus, and all types can coexist in diverse 
tissues of the same plant. For example, type 1 RIPs ebulitins (α, β, γ), the heterodimeric type 
2 RIP ebulin l and monomeric and homodimeric lectins (SELlm and SELld) are observed in 
the leaves of S. ebulus. The fruits of S. nigra express the type 1 RIPs nigritins (f1 and f2), 
both heterodimeric and tetrameric type 2 RIPs (nigrin f and SNAIf), and monomeric and 
homodimeric lectins (SNAIV and SELfd). The RIP level can change with plant development 
and during the seasons. Indeed, in young leaves of S. ebulus, the ebulin l level was higher 
than the level of the lectin SELld, but with the development of the plant, the ebulin l level 
decreased and disappeared during senescence, whereas the level of lectin increased (Rojo et 
al., 2003). Nigrin b, which is extracted from the bark of S. nigra provides another example of 
seasonal variation. High levels of this toxin are present in spring and summer, but not in 
winter (Ferreras et al., 2010).  
A sequence analysis of the RIPs of Sambucus demonstrated that they share an homology with 
ricin and other type 2 RIPs. The identity between the A chain and the B chain of ricin and 
ebulin l are 34 % and 48%,  respectively (Pascal et al., 2001).  
Based on X-ray diffraction analysis, ebulin l was shown to possess A and B chains similar to 
ricin, but with different galactose-binding properties. Ricin binds galactose and lactose in both 
subdomains 1 and 2 (at the 1α and 2γ sites, respectively). Ebulin l binds galactose and lactose 
similar to ricin, at the 1α sites, but it is unable to bind lactose at the 2γ site. Galactose binds 
differently whitin in the 2γ site of ebulin as compared with ricin; galactose bound is further 
into the binding cleft, and the different orientation and position may cause steric interference 
with the sugar attached to the C1 hydroxyl. The altered mode of galactose binding could alter 
the binding of this RIP to the cell surface and explain the low toxicity of this protein (Ferreras 
et al., 2010). 
Both type 1 and type 2 RIPs from Sambucus depurinate the rRNA and inhibit the protein 
synthesis, similar to ricin, in a cell-free system (rabbit reticulocytes) (IC50 of 0.15 nM, 0.003 
nM, and 0.10 nM for ebulin l, nigrin b and ricin, respectively) (Girbes et al., 1993a,b). 
Despite the high inhibition of protein synthesis in rabbit reticulocytes, the type 2 RIPs from 
Sambucus showed low cytotoxicity compared with ricin and other type 2 RIPs. For example, 
in Hela cells, the IC50 was 64.3 nM and 27.6 nM for ebulin l and nigrin b, respectively, 
whereas it was 0.00067 nM for ricin-treated cells (Citores et al., 1996). Their low toxic effect 
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was also observed in mice. The LD50 of ebulin l and nigrin b are 2 and 12 mg/kg body weight, 
respectively, whereas it is 0.003 mg/kg for ricin-treated mice (Girbes et al., 1993b; Battelli et 
al., 1997). Treating mice with an intravenous injection of a lethal dose of nigrin b (16 mg/kg) 
causes lesions in the intestine, with the disappearance of the villi and crypt structures. With 
sublethal doses (e.g., 5 mg/kg), the mice was completely recovered 9 days after the injection. 
In both cases, nigrin b caused apoptotic changes in the highly proliferating stem cells of the 
intestinal crypts (Gayoso et al., 2005). Recently, apoptotic changes were also observed in 
ebulin-treated mice (Jiménez et al., 2013). 
The different cytotoxicity among non-toxic and toxic type 2 RIPs, seems to be related to these 
proteins’ diverse interactions with cells and to the different routes used to enter the cells. The 
first hypothesis is supported by the finding that (i) ebulin l had a lower affinity for 
galactosides and, thus, for the galactose-containing glycoproteins and glycolipids present on 
the cell surface (Pascal et al., 2001) and (ii) nigrin b has lower affinity than ricin for Hela 
cells (Battelli et al., 2004). The second hypothesis is based in part on the finding that 
volkensin, another highly toxic type 2 RIP, has low affinity for Hela cells, suggesting that the 
low cytoxicity of ebulin l and nigrin b is not only caused by a weaker interaction with cells 
but could also depend on intracellular trafficking and processing pathways that are different 
from those of toxic type 2 RIPs. Nigrin b is distributed between cytoplasmic dots and Golgi 
compartment and is rapidly degraded; thus, exocytosed nigrin b is completely inactive 
(Battelli et al., 2004). Nigrin b may bind different glycoproteins on the plasma membrane and 
utilize a different intracellular routing than ricin. After internalization into the endosome, both 
toxic and non-toxic RIPs can be partially degraded in the lysosomes and then excreted, while 
another percentage of these RIPs can be recycled. After internalization into the endosomes, 
some ricin molecules can reach the Golgi apparatus and then be retrogradely transported to 
the ER, where the disufide bridge is reduced, and the A chain can translocate into the cytosol, 
where it inactivates the ribosomes. In contrast, nigrin b is translocated from the endosome to 
the cytosol when its extracellular concentration is very high, and then it can reach the 
ribosomes (Ferreras et al., 2010).  
Structure analysis showed that ricin possesses a lipase catalytic site, whereas ebulin l lacks 
this site. That absence of this lipolytic site, which has been implicated in the translocation and 
cytotoxicity of ricin, may also explain the lower cytotoxicity of ebulin l compared with ricin 
(Morloy-Guyot et al., 2003).  
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AIM OF THE PROJECT 
Nigrin b and ebulin l have been used to construct immunotoxins directed toward the 
transferring receptor (TfR), which is over-expressed in some cancer cells (Citores et al., 
2002), and to endothelial receptor CD105 (endoglin), which is strongly expressed in the blood 
vessels of tumor tissues (Benítez et al., 2005; Muñoz et al., 2007). These immunotoxins 
showed high cytotoxicity, with IC50 in the picomolar range. The previously obtained results 
suggest that non-toxic type 2 RIPs could be used for cancer therapy. Nigrin b and ebulin l 
show some advantages compared with toxic type 2 RIPs: (i) vascular leak syndrome should 
be less likely to develop; (ii) the free toxins released after hydrolysis of the conjugate do not 
cause significant toxic effects; and (iii) they are less dangerous to prepare than ricin (Ferreras 
et al., 2011). 
The aim of this work was to study the cell death mechanisms induced by the non-toxic type 2 
RIPs ebulin l and nigrin b because little is known about their pathogenic effects. The 
identification of the death pathway may be helpful for the selection of toxins that cause less 
necrosis, and thus fewer side effects, when used to construct immunotoxins.   
The pathogenesis of cell toxicity induced by these two RIPs was compared with the toxicity 
induced by toxic type 2 RIPs ricin and stenodactylin and the type 1 RIP saporin because of 
their different interactions with cells and their different internalization strategies.  
The ebulin l and nigrin b cytotoxicities were evaluated by studying caspase activation and 
viability in the presence of inhibitors of apoptosis and necroptosis.  
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RESULTS AND DISCUSSION 
5.1 The cytotoxic effects of Ebulin l and Nigrin b  
5.1.1 Inhibition of protein synthesis in vitro 
The enzymatic activity of two non-toxic type 2 RIP proteins purified from the leaves of 
S.ebulus (ebulin l) and the bark of S. nigrin (nigrin b) was evaluated in vitro in a cell-free 
system (rabbit reticulocyte lysate) using a non-radioactive method based on luciferase mRNA 
translation.  
The proteins were tested in reduced conditions to eliminate the steric hindrance of the B 
chain.  
The IC50, which were calculated by linear regression analysis, for the inhibition of protein 
translation were 8.7 ng/ml and 5.4 ng/ml for ebulin l and nigrin b, respectively (Fig. 5.1). 
These results are comparable to the IC50 already reported in literature (Ferreras et al. 2011).  
 
 
 
 
 
 
 
 
 
  
 
Fig. 5.1. Effect of ebulin l (A) and nigrin b (B) on  protein synthesis of a rabbit reticulocyte lysate cell-free 
system 
These results indicate that both RIPs efficiently inactivate ribosomes through their rRNA N-
glycosiladase activity. 
Table 5.1 shows that the IC50 of ebulin l and nigrin b are very similar to the values reported 
for the toxic type 2 RIP ricin and the type 1 RIP saporin, indicating that they have comparable 
enzymatic activity.  
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Table 5.1.  Effect of type 2 and type 1 RIPs on protein synthesis using the rabbit reticulocyte lysate system 
 
 
 
 
(* the high IC50 value of stenodactylin has been caused by an incomplete reduction of the molecule) 
5.1.2 Cell viability  
A previous study showed that nigrin b has a very low toxicity in different cell lines (Munoz et 
al., 2001). It is noteworthy that cell lines have different sensitivity to the lectins.  
A cell viability assay was performed using two cell lines: the human neuroblastoma NB100 
(Fig. 5.2) and the human colon carcinoma COLO320 (Fig. 5.3). NB100 was chosen for its 
high sensitivity to other RIPs that were previously tested in our laboratory.  
The cells were treated with RIP concentrations ranging from 10-13 M to 10-7 M, and the 
cytotoxicity was evaluated after 48 h using the MTS assay.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2. Effects of ebulin l and nigrin b on NB100 cell viability after 48 h at the indicated concentrations of the RIPs. 
Viability was evaluated using a colorimetric assay based on MTS reduction. The results are the means of three 
independent experiments, each performed in triplicate, and are presented as the percentage of control values obtained 
from cultures grown in the absence of RIPs 
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Fig. 5.3. Effects of ebulin l and nigrin b on COLO320 cell viability after 48 h at the indicated concentrations of 
the RIPs. Viability was evaluated using a colorimetric assay based on MTS reduction. The results are the means 
of three independent experiments, each performed in triplicate, and are presented as the percentage of the control 
values obtained from cultures grown in the absence of RIPs. 
The EC50 values were very similar both between the two toxins and between the two cell lines 
(Table 5.2). The NB100 cell line was not very sensitive to these two toxins, as compared with 
the other RIPs.  
 
 
Table 5.2.  Comparison of EC50 values calculated for the RIP ebulin l and nigrin b on NB100 and COLO320 
cells 
 
 
 
 
 
 
 
When comparing the EC50 of the toxic type 2 RIPs stenodactylin and ricin and the type 1 RIP 
saporin, which were calculated previously (Chapter 4), with those of ebulin l and nigrin b in 
NB100 cells (Table 5.3), it is notable that the RIPs from Sambucus showed lower cytotoxicity 
than the other RIPs, even than saporin. The EC50 were almost the same for both ebulin l and 
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nigrin b; and the EC50 of both non-toxic type 2 RIPs were 3, 5 and 6 orders of magnitude 
higher than the EC50 of saporin, ricin and stenodactylin, respectively. The enzymatic activity 
was almost identical between the RIPs, whereas the cytotoxic activity was very different 
between the non-toxic and the toxic RIPs. These differences could be caused by a diverse 
number of cell receptors, and/or by different sugar binding sites between the Sambucus RIPs 
and the toxic type 2 RIPs. However, the non-toxic type 2 RIPs were less toxic than even 
saporin, which present low (if any) binding affinity to the receptors. These results confirm the 
hypothesis that a different routing and possibly intracellular modifications may explain the 
low cytotoxicity of ebulin l and nigrin b.  
 
Table 5.3.  Comparison of type 2 (toxic and non-toxic) and type 1 RIPs  toxicities to NB100 cells 
 
 
 
 
 
5.1.3 Evaluation of cell death 
Because the non-toxic type 2 RIPs exhibited low cytotoxicity, the experiments were 
conducted with a concentration that was 10 times higher than the IC50, corresponding to 10-7 
M. 
To understand the cell death mechanism induced by ebulin l and nigrin b, NB100 cells were 
stained with Annexin V-EGFP/PI and analyzed by flow cytometry. PI-positive cells are in the 
upper left quadrant, while cells in late and early apoptosis are in the upper and lower right 
quadrants, respectively. After a 48 h of intoxication, more than 10% of the treated cells were 
in the late apoptosis stage; this percentage increased with time, reaching 35.8% and 31.2% for 
ebulin l and nigrin b, respectively. Interestingly, a small percentage of cells (higher in nigrin 
b-treated cells) were only positive for PI, suggesting death through a mechanism other than 
apoptosis (Fig. 5.4).  
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Fig. 5.4. Apoptosis as detected with Annexin V-EGFP/PI staining followed by flow cytometry analysis. 
Representative plots of Annexin V-EGFP/PI staining of NB100 cells cultured in the absence or presence of 
ebulin l (10-7 M) and nigrin b (10-7 M) at 48 h and 72 h. 
To evaluate whether ebulin l and nigrin b could induce caspase-dependent apoptosis, caspase 
3/7 activation was assessed at different time points. The results showed that the two RIPs 
activated caspases 3/7 in a time-dependent manner. The effector caspases became 
significantly activated after 8 h of intoxication and increased exponentially over time, 
reaching 700% and 450% with ebulin l and nigrin b, respectively, after 24 h of intoxication 
(Fig. 5.5). 
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Fig. 5.5. Caspases 3/7 activation in NB100 cells treated with ebulin l (10-7 M) and nigrin b (10-7 M). Caspase 
activity was expressed as the percentage of control values obtained from cultures grown in the absence of RIPs. 
Means results ± S.D are reported. The asterisk indicate level of significance in ANOVA Dunnett’s test  (*** 
p=0.001). 
Previous studies, reported in chapter 4, have shown that stenodactylin and ricin, at their IC50 
concentration, could induce caspases 3/7 activation in NB100 cells after 4 h of exposition to 
the toxin, whereas with saporin, the effector caspases began being significantly activated after 
16 h of exposure to the toxin.  
Comparing the caspase 3/7 activity after 24 h with stenodactylin, ricin, and saporin and the 
non-toxic type 2 RIPs, the activation of effector caspases was much lower with ebulin l and 
nigrin b than with the other RIPs, including saporin (Table 5.4). These results suggest that 
ebulin l and nigrin b induce a caspase-dependent apoptosis but require longer time than the 
type 2 RIPs, not to initiate activation but to significantly induce caspases activation. 
 
Table 5.4.  Caspase 3/7 activation of type 2 RIP (toxic and non-toxic) and type 1 RIP after 24 h of treatment 
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To evaluate the role of different cytotoxic mechanisms induced by the Sambucus toxins, 
NB100 cells were pretreated with two inhibitors, the pan-caspase inhibitor Z-Vad and the 
inhibitor of necroptosis, necrostatin-1 (Fig 5.6). 
.  
 
 
 
 
 
 
 
 
 
Fig 5.6. Time-course experiments with NB100 cells exposed to ebulin l (10-7 M) and nigrin b (10-7 M) after a 
pretreatment with 100µM necrostatin (Necro) or 100 µM Z-Vad or exposed to RIP alone. The inhibitors were 
added every 24 h Viability was evaluated at the indicate times with a colorimetric assay basesd on MTS 
reduction. The results are the means of three independent experiments, with each performed in triplicate, and are 
presented as the percentage of control values obtained from cultures grown in the absence of RIPs. Asterisks 
indicate level of significance in ANOVA, Dunnett’s test  (***p=0.001). 
Surprisingly, these preliminary results showed that at 24 h, there was no difference in viability 
in the presence or absence of the inhibitors. At 48 h and 72 h, the presence of Z-Vad 
improved cell survival. In particularly, at 48 h, viability increased from 39% to 68% in ebulin 
l-treated cells and from 35% to 69% in nigrin b-treated cells, whereas at 72 h viability 
increased from 5% to 24% in ebulin l- and nigrin b-treated cells. In contrast, necrostatin did 
not rescue ebulin l-induced cell death, whereas a slight, but significant, protective effect was 
observed after 48 h of treatment with nigrin b. However, the rescue observed was much lower 
than the rescue observed with Z-Vad. These data suggest that the cell death mechanism 
induced by non-toxic type 2 RIPs is partially due to a caspase-dependent apoptotic pathway. 
However, because Z-Vad does not provide total protection and because necrostatin-1 offers 
little or no protection, a different type of cell death, in addition to apoptosis, should be present 
in NB100 cells treated with ebulin l, and nigrin b. Necrosis or necroptosis may be partially 
involved in cell death mechanism.  
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When L540 cells are incubated with saporin and ricin, Z-Vad caused a strong improvement in 
cell survival (Polito et al., 2009a). A strong protective effect of Z-Vad has been observed also 
in NB100 cells treated with stenodactylin (Chapter 4). In treated L540 and NB100, the effect 
of necrostatin-1 was smaller than the effect observed with Z-Vad. Taking together, these 
observations and the data for caspases 3/7 suggest that in stenodactylin-, ricin- and saporin- 
treated cells, the apoptotic pathway is the faster, dominant cell death mechanism, whereas the 
same is not observed for ebulin l- and nigrin b- treated cells.  
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RIPs are a family of plant proteins that damage ribosomes, with consequent arrest of protein 
synthesis. Although various pathways have been proposed by which type 1 and type 2 RIPs 
can trigger cell death, the detailed molecular mechanisms are still unclear. 
The purpose of this research project was to increase the knowledge about the most toxic type 
2 RIPs stenodactylin (by studying the amino acid sequence and its cytotoxic effect), and the 
pathogenic effect of non-toxic type 2 RIPs ebulin l and nigrin b.  
 
The amino acid sequence of stenodactylin showed a high degree of identity with volkensin 
and with amino acid residues that are involved in the active site of both type 1 RIPs and the A 
chain of type 2 RIPs. The carbohydrate-binding sites of the B chain were highly homologous 
between stenodactylin and the other RIPs. The B chain of stenodactylin contains a positive 
charge in the 2γ binding site; substitution for this charge seems to be correlated with the lower 
cytotoxicity of other RIPs. Moreover, a phylogenetic tree showed that the B chain of 
stenodactylin is more related to non toxic type 2 RIPs than to ricin. Both results are surprising 
because stenodactylin is actually the most toxic type 2 RIP.  
The knowledge of the amino acid sequence of stenodactylin will allow studies of site-directed 
mutagenesis to construct less immunogenic recombinant immunotoxins and to identify the 
residues that underlie its high cytotoxicity. Moreover, the amino acid sequence, together with 
the previously published crystallographic analysis, will be used to determinate the three-
dimensional structure, which could further clarify the molecular basis of the high toxicity of 
this protein.  
 
The studies on the cell death mechanisms induced by stenodactylin on NB100 cells 
showed that high doses of this toxin can activate the effector caspases (perhaps through the 
DNA damage and/or intrinsic/extrinsic pathways) and also causes ROS generation, which 
appear to be important mediators of stenodactylin-induced cell death. The results suggest that 
the production of ROS in stenodactylin-treated cells mainly causes caspase-dependent 
apoptosis, but other cell death mechanisms, such as necroptosis, are also induced. These 
results indicate that stenodactylin induces damage as a consequence of a multi-directional 
pathway, and apoptosis appears to be the fastest and most strongly induced cell death 
mechanism. 
Testing low doses of stenodactylin, ricin and saporin has allowed us to observe that the 
caspases activation is independent from the inhibition of protein synthesis. Moreover, the 
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extrinsic apoptotic pathway seems to be the main mechanism that is activated in 
stenodactylin- treated cells. 
Future studies will clarify the alternative cell death mechanisms induced by low doses of 
stenodactylin, for example, by studying the expression of genes that are involved in 
necroptosis or other cell death pathways (e.g., autophagy). The same studies will be 
conducted in various cell lines because different cell lines show different sensitivity to RIPs, 
most likely due to the induction of alternative cell death mechanisms. Because several factors 
that affect cell machinery could be responsible for cell death, a better knowledge of the cell 
death mechanisms induced by stenodactylin may have important consequences for its 
medicinal use. 
 
The assessment of toxicity induced by ebulin l and nigrin b showed a strong enzymatic 
activity in a cell-free system compared with ricin, stenodactylin and saporin but a low 
cytotoxic effect on NB100 cells even when compared with saporin. The two non-toxic type 2 
RIPs induced the activation of caspases 3/7 but to a lower extent than the other RIPs. These 
preliminary studies showed that caspase-dependent apoptosis is only partially involved in the 
cell death mechanism induced by ebulin l and nigrin b. Moreover, nigrin b caused a slight but 
significant activation of the necroptotic pathway.  
Future studies are required to understand the other cell death mechanisms induced by ebulin l 
and nigrin b, and the involvement of reactive oxygen species and autophagy. 
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